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Legal Disclaimer
The guidelines for medical fitness to drive Slánte agus Tiomáint (‘the Guidelines’) have been compiled by the Road
Safety Authority in conjunction with the National Programme Office for Traffic Medicine* using all reasonable care
and based on expert medical opinion and relevant literature at the time of printing. However, they are published for
guidance purposes only and neither the Road Safety Authority nor the National Programme Office for Traffic Medicine
nor the Royal College of Physicians of Ireland to which it is also associated accepts responsibility for any consequences
arising from their application, including any liability in respect of any claim or cause of action arising out of, or in
relation to, the use or reliance on the Guidelines.
Health professionals should keep informed of any changes in health care and health technology that may affect their
assessment of drivers. They should also maintain an awareness of any changes in the law that may affect their legal
responsibilities.
* The National Programme Office for Traffic Medicine was established as a joint initiative between the Road Safety Authority and the Royal College of Physicians 
of Ireland of Ireland, in 2010.
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Foreword
Sláinte agus Tiomáint provides guidance on medical fitness for drivers and highlights the need for all of us to appreciate
that the state of our health impacts, to a greater or lesser degree, on our ability to drive safely. Driver fitness is governed
by EU law and regulations made in Ireland under the Road Traffic Acts. Sláinte agus Tiomáint is an interpretation of
these laws; however, the Directive/regulations form the overriding legal basis for driver medical fitness in Ireland. 
One of the objectives of Sláinte agus Tiomáint is to promote mobility and to do this in a way that is consistent with
safety on our roads. Once a driver is aware of any health aspects that impact on driving and follows the advice of their
doctor, they can continue to drive in most cases.
It is intended that Sláinte agus Tiomáint forms one part of a broader information and communication campaign to
increase awareness among medical professionals and the wider public about fitness to drive. Sláinte agus Tiomáint
was developed by the National Programme Office for Traffic Medicine which has been established as a joint initiative
between the Road Safety Authority and the Royal College of Physicians of Ireland. In developing the guidelines, 
the National Programme Office for Traffic Medicine engaged widely with stakeholders to ensure that they reflect 
good practice.
The Office is also working to ensure that all doctors, healthcare disciplines, medical professionals, An Garda Siochana 
and transport professionals have training and support for the practical implementation of the guidelines on the ground.
Sláinte agus Tiomáint is an important addition to the range of initiatives that ensures we can continue to drive safely 
on our roads.
Noel Brett CEO
Road Safety Authority
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Part A: General information
Chapter 1
1.0 Introduction
This publication summarises Irish medical guidelines of fitness to drive. The information in these Guidelines are
intended to assist doctors and other healthcare professionals in advising their patients on fitness to drive,
requirements for reporting to their Driving Licensing Authority and guidance on review of stability, progression or
improvement of these conditions. It should be used by health professionals when:
• Treating any patient who holds a driver licence whose condition may impact on their ability to drive safely. The
majority of adults drive, thus a health professional should routinely consider the impact of a patient’s condition
on their ability to drive safely. Awareness of a patient’s occupation or other driving requirements is also helpful.
• Undertaking an examination at the request of a Driving Licensing Authority
– Assessing a person whose driving the Driving Licensing Authority believes may be unsafe 
(i.e. ‘for cause’ examinations)
– For licence renewal of an older driver
This publication focuses on long-term health and disability-related conditions and their associated functional effects
that may impact on driving. It sets out clear minimum medical requirements for licensing and forms the medical basis
of decisions made by the Driving Licence Authority. This publication also provides general guidance with respect to
patient management for fitness to drive. 
These medical standards refer to Group 1 licence holders only. Group 1 includes motor cars for private use and
motorcycles.
These guidelines are a part of a larger project of the National Programme Office for Traffic Medicine a joint initiative
between the Road Safety Authority and the Royal College of Physicians of Ireland. This larger project will encompass
Group 2 guidelines, and will develop proposals for supporting medical fitness to drive through education, research
and developments such as conditional or restricted licences
Group 1 categories A, A1 , A2, AM,B, BE, or W i.e motorcycles, cars and tractors (with or without trailer)
Group 2 C, CE, C1, C1E, D, DE, D1 or  D1E i.e trucks and buses (without trailer)
The vehicles in Group 2 are regarded as higher-risk vehicles which require a higher standard of physical and
mental fitness on the part of the driver
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1.1 Traffic medicine and the compilation of the guidelines
Although the first automobile fatality in the world occurred in Ireland in 18591, Traffic Medicine is a relatively new
specialism embracing all those disciplines, techniques, and methods aimed at reducing the harm traffic crashes inflict
on human beings (International Traffic Medicine Association, 2009). There is also an enabling/rehabilitative element
which tries to ensure that transport mobility (an important constituent of well-being and social inclusion) is not
hampered, or rendered unsafe, by remediable illness or functional loss.
It involves a wide range of disciplines, with a rapidly increasing research database which encompasses an active
process of reflection, debate and consensus to maximise safe mobility. The most visible face of Traffic Medicine in
most jurisdictions is the ‘medical fitness to drive’ aspect of driver licensing. Support for the approach of using
evidence-based guidelines is provided by evidence of a significant drop in crashes among drivers when such guidelines
are systematically applied2.
These guidelines represent a synthesis of current research and clinical practice on medical fitness to drive as
interpreted by the National Programme Office for Traffic Medicine, a joint initiative of the Road Safety Authority and
the Royal College of Physicians of Ireland (see Acknowledgements). The contributors included virtually every medical
specialty relevant to medical fitness to drive, as well as associated disciplines, the Irish Patients’ Association, the
Garda Síochána and the Automobile Association.
We are fortunate to be able to formally work with, and draw on the experience of, the Driver and Vehicle Licensing
Authority (DVLA) of the United Kingdom. The Irish guidelines are based on its ‘At a Glance Guide to the current
Medical Standards of Fitness to Drive’, and some of the specialist contributors to the Guidelines are honorary
members of the Advisory Panels of the DVLA. These Panels, which meet biannually consist of doctors and other
professionals eminent in the respective fields of Cardiology, Neurology, Diabetes, Vision, Alcohol/Substance Misuse
and Psychiatry together with lay members. Consequently, both the Irish and UK standards are reviewed and updated
regularly. Whilst every effort has been made to ensure the accuracy of the information contained, no guarantees can
be given concerning the completeness or up-to-date nature of the information provided in-these Guidelines, which are
only accurate at the time of publication. Health Professionals should keep themselves up-to-date with changes in
medical knowledge and technology that may influence their assessment of drivers, and with legislation that may
affect the duties of the health professional or the patient. Therefore, neither the Road Safety Authority nor the
National Programme Office for Traffic Medicine nor the Royal College of Physicians of Ireland accept liability
whatsoever arising from errors or omissions in the Guidelines.
It is also emphasised that these Guidelines are for use as guidance only, and should be viewed in the context of
appropriate Continuing Professional Development on the topic of medical fitness to drive, as well as referral for
appropriate specialist advice. 
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1. Fallon I, O'Neill D. The world's first automobile fatality. Accid Anal Prev 2005 Jul;37(4):601-3.
2. Redelmeier DA, Yarnell CJ, Thiruchelvam D, Tibshirani RJ. Physicians' warnings for unfit drivers and the risk of trauma from road crashes. 
N Engl J Med. 2012 Sep 27;367(13):1228-36.
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Table 1: Roles and responsibilities of drivers, health professionals and driver licensing authorities
Driver
• To report to the Driving Licensing Authority and their insurance provider any long-term or permanent injury or
illness that may affect their ability to drive safely: if holding a licence from an EU country other than Ireland, 
or a recognised country for licence exchange, and developing a condition which could affect safe driving, the
driver must contact the licensing authority to arrange for an exchange of their licence.
• To respond truthfully to questions from the health professional regarding their health status and the likely
impact on their driving ability. 
• To adhere to prescribed medical treatment and monitor and manage their condition(s) and any adaptations
with ongoing consideration of their fitness to drive. 
• To comply with requirements of their licence as appropriate, including periodic medical reviews. 
Health professional
• To assess the person’s medical fitness to drive based on the current Sláinte agus Tiomaint medical standards. 
• To advise the person regarding the impact of their medical condition or disability on their ability to drive and
recommend restrictions and ongoing monitoring as required.
• To advise the person of their responsibility to report their condition to the Driving Licensing Authority if their
long-term or permanent injury or illness may affect their ability to drive safely. 
• To treat, monitor and manage the person’s condition with ongoing consideration of their fitness to drive. 
• To report to the Driving Licensing Authority regarding a person’s fitness to drive in the exceptional
circumstances where there is a risk to the public and the driver cannot or will not cease driving. 
Licensing authority
• To make all decisions regarding the licensing of drivers. The Driving Licensing Authority will consider reports
provided by health professionals. 
• To inform the driving public of their responsibility to report any long-term or permanent injury or illness to
the Driving Licensing Authority if the condition may affect their ability to drive safely. 
• Will act on reports of third parties, Gardai, general public and healthcare workers regarding concerns of public
safety relating to medical fitness to drive. 
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2.0 Roles and responsibilities
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2.1 Roles and responsibilities of Driving Licensing Authority
The responsibility for issuing, renewing, suspending, refusing or cancelling a person’s driving licence lies ultimately
with the Driving Licensing Authority. Licensing decisions are based on a full consideration of relevant factors relating
to the driver’s health and driving performance record. In making a licensing decision, the authority will seek input
regarding a person’s medical fitness to drive, either directly from the driver and/or from a health professional. Where
appropriate, the authority will also consider unsolicited reports from health professionals, the police or members of
the public regarding a person’s fitness to drive. Payments for health examinations or assessments related to fitness to
drive are not the responsibility of the Driving Licensing Authority.
2.2 Roles and responsibilities of drivers
Irish and EU legislation requires that a driver should advise their Driving Licensing Authority of any long-term or
permanent injury or illness that may affect their safe driving ability.
At licence application and renewal, drivers complete a declaration regarding their health, including whether they
have any long-term conditions such as diabetes, epilepsy or cardiovascular disease. Based on this information, the
Driving Licensing Authority may request a medical examination to confirm a driver’s fitness to hold a driver licence. 
In the case of medical examinations requested by the Driving Licensing Authority, drivers have a duty to declare their
health status to the examining health professional.
Drivers are also required to report to the Driving Licensing Authority when they become aware of a health condition
that may affect their ability to drive safely. 
A driver should not drive while medically unfit to do so and can be convicted of an offence for doing so. Under
Sections 32 and 48 of the Road Traffic Act 1961, drivers should be aware that there may be long-term financial,
insurance and legal consequences where there is failure to report an impairment to their Driving Licensing Authority
and insurance provider.
Drivers must adhere to prescribed medical treatment and monitor and manage their condition(s) and any adaptations
with ongoing consideration of their fitness to drive.
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An appeals mechanism is available for drivers who have been refused a licence on medical grounds. The Driving
Licensing Authority will  inform drivers of the appeals process when informing them of the licensing decision.
Regulations 12 and 20 of the Road Traffic (Licensing of Drivers) Regulations 2006, Statutory Instruments Number
537 of 2006, as amended by the Road Traffic (Licensing of Drivers) (Amendment) (No. 2) Regulations 2010,
Statutory Instruments Number 544 of 2010, give effect to Commission Directives regarding medical criteria for
certification of fitness to drive.
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2.3 Roles and responsibilities of health professionals
Patients rely on health professionals to advise them if a permanent or long-term injury or illness may affect their safe
driving ability, and whether it should be reported to the Driving Licensing Authority. The health professional has an
ethical obligation, and potentially a legal one, to give clear advice to the patient in cases where an illness or injury
may affect safe driving ability, and to maximise health and function so as to facilitate ease and safety of driving. 
There may be options other than complete cessation of driving where a patient presents with a particular condition, 
a restriction such as a modified breaking system can be coded on the driving licence allowing for safer mobility. In the
future the RSA will be providing for additional codes which will include a code for restricting driving to daytime only.
Health professionals are advised to note in the medical record the nature of the advice given.
2.3.1 Confidentiality, privacy and reporting to the Driving Licensing Authority
Health professionals have both an ethical and legal duty to maintain patient confidentiality. The ethical duty is
generally expressed through codes issued by professional bodies. The legal duty is expressed through legislative and
administrative means, and includes measures to protect personal information about a specific individual. The duty to
protect confidentiality also applies to Driving Licence Authority.
The patient–professional relationship is built on a foundation of trust. Patients disclose highly personal and sensitive
information to health professionals because they trust that the information will remain confidential. If such trust is
broken, many patients could either forego examination/treatment and/or modify the information they give to their
health professional, thus placing their health at risk.
Although confidentiality is an essential component of the patient–professional relationship, there are, on rare
occasions, ethically and/or legally justifiable reasons for breaching confidentiality. With respect to assessing and
reporting fitness to drive, the duty to maintain confidentiality is legally qualified in certain circumstances in order to
protect public safety. The Irish Medical Council guidelines provide for breach of confidentiality if the driver represents
a risk to the safety of others, refuses or cannot inform the licensing authority, fails to stop or adapt driving appropriately,
and is not amenable to appropriate persuasion and discussion. The health professional should consider reporting
directly to the Driving Licence Authority in situations where the patient is either:
• Unable to appreciate the impact of their condition; or 
• Unable to take notice of the health professional’s recommendations due to cognitive impairment; or 
• Continues driving despite appropriate advice and is likely to endanger the public.
A positive duty is imposed on health professionals to notify the relevant authority in writing of a belief that a driver is
physically or mentally unfit to drive, poses a risk to public safety and is not compliant with professional advice to stop
driving. It is preferable that any action taken in the interests of public safety should be taken with the consent of the
patient wherever possible and should certainly be undertaken with the patient’s knowledge of the intended action to
the greatest extent possible. The patient should be fully informed as to why the information needs to be disclosed to
the Driving Licence Authority, and be given the opportunity to consider this information. Failure to inform the patient
will only exacerbate the patient’s (and others’) mistrust in the patient–professional relationship.  
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It is recognised that there might be an occasion where the health professional feels that informing the patient of the
disclosure may place the health professional at risk of violence. Under such circumstances, the health professional
must consider how to appropriately manage such a situation. In making a decision to report directly to the Driving
Licensing Authority, it may be useful for the health professional to consider:
• The seriousness of the situation (i.e. the immediate risks to public safety).
• The risks associated with disclosure without the individual’s consent or knowledge, balanced against the
implications of non-disclosure.
• The health professional’s ethical and professional obligations. 
• Whether the circumstances indicate a serious and imminent threat to the health, life or safety of any person.
Examinations requested by a Driving Licensing Authority
When a patient presents for a medical examination at the request of a Driving Licence Authority, the situation is
different with respect to confidentiality. The patient will present with a form or letter from the Driving Licence
Authority, requesting an examination for the purposes of licence application or renewal, or as a stipulation of a
conditional licence. The completed form will generally be returned by the patient to the Driving Licence Authority,
thus there is no risk of breaching confidentiality or privacy, provided only information relevant to the patient’s 
driving ability is included on the form, and a copy of the form/report should be retained by the assessing clinician. 
Privacy legislation
All health professionals and the Driving Licence Authority should be aware of data protection and other applicable
legislation when collecting and managing patient information and when forwarding such information to third parties. 
2.3.2 Patient–health professional relationship
It is expected that the health professional will be able to act objectively in assessing a patient’s fitness to drive. If this
cannot be achieved, for example, where there may be the possibility of the patient ceasing contact or avoiding all
medical management of their condition, health professionals should be prepared to disqualify themselves and refer
their patient to another practitioner.
2.3.3 Patient hostility towards the health professional
Sometimes patients feel affronted by the possibility of restrictions to their driving or withdrawal of their licence, and
may be hostile towards their treating health professionals. In such circumstances, the health professional may elect
to refer the driver to another practitioner or may refer them directly to the Driving Licence Authority without a
recommendation regarding fitness to drive. The Driving Licence Authority recognise that it is their role to enforce the
laws on driver licensing and road safety and will not place pressure on health professionals that might needlessly
expose them to risk of harassment or intimidation.
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2.3.4 Dealing with individuals that are not regular patients
Care should be taken when health professionals are dealing with drivers who are not regular patients. Some drivers
may seek to deceive health professionals about their medical history and health status, and may ‘doctor shop’ for a
desirable opinion. If a health professional has doubts about an individual’s reason for seeking a consultation, they
should consider:
• Asking permission from the individual to request their medical file from their regular health professional. 
• Conducting a more thorough examination of the individual than would usually be undertaken. 
2.4 Role of the consultant
In most circumstances, medical assessments of drivers can be conducted by a general practitioner. However, if doubt
exists about a patient’s fitness to drive or if the patient’s particular condition or circumstances are not covered
specifically by the standards, review by a consultant experienced in the management of the particular condition is
warranted and the general practitioner should refer the patient to such a specialist.
If in doubt about the patient’s suitability to drive, referral to a further specialist and associated multi-disciplinary
team (i.e. physiotherapy, occupational therapy, psychology, optometrist) and/or on-road testing with a driving
assessor qualified to assess driving among those with disabilities may be of assistance.
2.4.1 Documentation
Clear documentation of the assessment results and communication with the patient and Driving Licence Authority 
is important, as well as maintenance of a record of decisions and advice given to the driver. To aid this process, a
Patient Advisory Form is available that provides written information that can be given to the patient and it is also
advisable to keep this form on file.
3.0 General considerations for assessing fitness to drive
The aim of determining fitness to drive is to achieve a balance between minimising any driving-related road safety
risks for the individual and the community posed by the driver’s permanent or long-term injury or illness, and main-
taining the driver’s lifestyle and employment-related mobility independence. Indeed, for many conditions, remedia-
tion and rehabilitation may improve driver comfort and safety.
The following pages outline the general principles and considerations for assessing driver fitness. Also included in 
this section is a summary of the assessment process. These principles should be considered in conjunction with the
specific standards outlined in Part B of this publication.
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3.1 Requirements of the driving task
Consideration of the requirements of the driving task is fundamental to assessing a person’s medical fitness to drive.
The driving task involves a complex and rapidly repeating cycle that requires a level of skill and the ability to interact
with both the vehicle and the external environment at the same time. Information about the road environment is
obtained via the visual and auditory senses. The information is operated on by many cognitive processes including
short and long-term memory and judgement, which leads to decisions being made about driving. Decisions are put
into effect via the musculoskeletal system, which acts on the steering, gears and brakes to alter the vehicle in relation
to the road. 
The overall process is co-ordinated via a complex process involving behaviour, strategic and tactical abilities and
personality3, and adaptive strategies are important in maintaining safe driving in the face of illness and disability4. 
This repeating sequence depends, among other elements, on:
• Vision
• Visio-spatial Perception 
• Hearing
• Attention and Concentration 
• Memory
• Insight
• Judgement
• Adaptive Strategies
• Reaction Time 
• Sensation
• Muscle Power 
• Co-ordination
Given these requirements, it follows that many body systems need to be functional in order to ensure safe and timely
execution of the skills required for driving. 
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Table 2: Environmental factors affecting driving performance
Driving tasks occur within a dynamic system influenced by complex driver, vehicle, task, organisational and
external road environment factors including:
• The driver’s experience, training and attitude. 
• The driver’s physical, mental and emotional health, including fatigue and the effect of prescription and 
non prescription (over the counter) medicines. 
• The road system, for example, signs, other road users, traffic characteristics and road layout. 
• Legal requirements, for example, speed limits and blood alcohol concentration. 
• The natural environment, for example, night, extremes of weather and glare. 
• Vehicle and equipment characteristics, for example type of vehicle, braking performance and maintenance. 
• Personal requirements, trip purpose, destination, appointments, time pressures etc.
• Passengers and their potential to distract the driver.
3. Fuller R. Towards a general theory of driver behaviour. Accid Anal Prev 2005;37(3):461-72.
4. Langford J, Braitman K, Charlton J, Eberhard J, O'Neill D, Staplin L, Stutts J. TRB Workshop 2007: Licensing authorities' options for managing older driver 
safety practical advice from the researchers. Traffic Inj Prev 2008;9(4):278-81.
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3.2 Medical conditions likely to affect fitness to drive
Given the many causal factors in motor vehicle crashes, the extent to which medical conditions contribute is difficult
to assess. There is, however, recognition of the potential for certain conditions to cause serious impairments.
Examples of such conditions include:
•     Blackouts
•     Cardiovascular Disease 
•     Diabetes
•     Musculoskeletal Conditions
•     Neurological Conditions such as Epilepsy, Dementia and Cognitive Impairment due to other causes 
•     Psychiatric Conditions 
•     Substance Misuse/Dependency 
•     Sleep Disorders 
•     Vision Problems
Treatments for medical conditions (including drug treatments and others) can also affect driving ability positively or
negatively through effects on cognition and reaction time. 
Drivers may present to treating health professionals with a range of conditions, some that affect driving temporarily,
or may affect the patient’s ability to drive at some time in the future, or that are complicated by the presence of
multiple conditions. The content of this publication focuses on common conditions known to affect fitness to drive
and, in particular, on determining the risk of a patient’s involvement in a serious vehicle crash caused by loss of
control of the vehicle. 
It is accepted that other medical conditions or combinations of conditions may also be relevant and that it is not
possible to define all clinical situations where an individual’s overall function would compromise public safety. A
degree of professional judgement, with more extensive assessment or specialist opinion as required, is therefore
required in assessing fitness to drive.
Should a clinician require further assessment of a patient (for example, occupational therapy, specialist opinion or 
on-road test), the doctor in charge of their care should be able to advise the driver whether or not it is appropriate for
them to continue to drive during the period until these further assessments have been completed. Patients may be
reminded that if they choose to ignore medical advice to cease driving, there could be consequences with respect to
their insurance cover. 
3.3 Temporary conditions
There is a wide range of conditions that temporarily affect the ability to drive safely. These include conditions such as
post major surgery, severe migraine, or injuries to limbs. These conditions are self-limiting and hence do not impact
on licence status; therefore, the licensing authority need not be informed. However, the treating health professional
should provide suitable advice to such patients regarding driving safely. Such advice should be based on consideration
of the likely impact of the patient’s condition and their specific circumstances on the driving task as well as their
specific driving requirements. Table 3 provides guidance on some common conditions that may temporarily impact on
driving ability. Note: this publication does not attempt to address every condition or situation that might temporarily
affect safe driving ability. See following table for examples of management of temporary conditions.
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Table 3: Examples of management of temporary conditions
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Condition and impact on driving
Anaesthesia
Physical and mental capacity may be impaired for some
time post anaesthesia (including both general and local
anaesthesia). The effects of general anaesthesia will
depend on factors such as duration of anaesthesia, the
drugs administered and the surgery performed. The
effect of local anaesthesia will depend on dosage and 
the region of administration. The use of analgesics and
sedatives should also be considered.
Post surgery
Surgery will impact on driving ability to varying degrees
depending on the location, nature and extent of the
procedure.
Pregnancy
Under normal circumstances pregnancy should not be
considered a barrier to driving. However, conditions
that may be associated with some pregnancies should
be considered when advising patients. These include:
• Fainting or light-headedness
• Hyperemesis gravidarum
• Hypertension of pregnancy
• Post caesarean section
Temporary or short-term vision impairments
A number of conditions and treatments may impair
vision in the short term, for example, temporary
patching of an eye, use of my driatics or other drugs
known to impair vision, or eye surgery. For long-term
vision problems, refer to Part B, section 7, Vision and
eye disorders.
Deep vein thrombosis and pulmonary embolism
While deep vein thrombosis may lead to an acute
pulmonary embolus there is little evidence that such 
an event causes crashes. Therefore there is no licensing
standard applied to either condition. Non-driving
periods are advised.
Management guidelines
In cases of recovery following surgery or procedures
under general or local anaesthesia, it is the
responsibility of the surgeon/dentist and anaesthetist
to advise patients not to drive until physical and mental
recovery is compatible with safe driving.
• Following minor procedures under local anaesthesia
without sedation (e.g. dental block), driving may 
be acceptable immediately after the procedure. 
• Following brief surgery or procedures with short-
acting anaesthetic drugs, the patient may be fit
to drive after a normal night’s sleep. 
• After longer surgery or procedures requiring 
general anaesthesia, it may not be safe to drive 
for 24 hours or more. 
The non-driving period post surgery should be
determined by the treating health professionals.
A caution regarding driving may be required depending
on the severity of symptoms and the expected effects 
of medication.
People whose vision is temporarily impaired by a 
short-term eye condition or an eye treatment should 
be advised not to drive for an appropriate period.
Group 1 drivers should be advised not to drive for at
least two weeks following a deep vein thrombosis and
for six weeks following a pulmonary embolism.
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3.4 Undifferentiated conditions
A patient may present with symptoms that could have implications for their licence status but the diagnosis is not
clear. Investigation of the symptoms will mean there is a period of uncertainty before a definitive diagnosis is made
and before the licensing requirements can be confidently applied.
Each situation will need to be assessed individually, with due consideration being given to the probability of a serious
disease or long-term or permanent injury or illness that may affect driving, and to the circumstances in which driving
is required. However, patients presenting with symptoms of a potentially serious nature, for example, chest pains,
dizzy spells or black-outs, or delusional states should be advised not to drive until their condition can be adequately
assessed. During this interim period, in the case of private vehicle drivers, no formal communication with the Driving
Licensing Authority is required. After a diagnosis is firmly established and the standards applied, normal notification
procedures apply, if needed. The health professional should consider the impact on the driver’s livelihood and
investigate the condition as quickly as possible.
3.5 Multiple conditions and age-related change
Where a vehicle driver has multiple conditions or a condition that affects multiple body systems, there may be an
additive or a compounding detrimental effect on driving abilities, for example, in:
• Congenital disabilities such as cerebral palsy, spina bifida and various syndrome. 
• Multiple trauma causing orthopaedic and neurological injuries as well as psychiatric sequelae.
• Multi-system diseases such as diabetes, connective tissue disease and HIV. 
• Dual diagnoses involving psychiatric illness and drug or alcohol addiction. 
• Ageing-related changes in motor, cognitive and sensory abilities together with degenerative disease. 
• Fatigue related to cancer and neurological conditions.
Although these medical standards are designed principally around individual conditions, clinical judgement is 
needed to integrate and consider the effects on safe driving of any medical conditions and disabilities that a patient
may present with. For example, glaucoma may cause a slight loss of peripheral vision. If combined with cervical
spondylosis and low insight, there is likely to be a substantial reduction in the driver’s visual fields and possibly 
their perceptual abilities, thus increasing the risks of missing important visual information when driving.
Advanced age, in itself, is not a barrier to driving, and functional ability rather than chronological age should be the
criterion used in assessing the fitness to drive of older people, although physicians should be mindful that multi-
morbidity increases with age5. Age-related physical and mental changes vary greatly between individuals but will
eventually affect the ability to drive safely. Professional judgement must determine what is acceptable decline
(compensated by the patient’s long experience and self-imposed limitations on when and where they drive) and what
is irreversible, hazardous deterioration in driving-related skills, requiring reporting to the licensing authority. This may
require careful consideration and specialist referral. As all possible combinations of disabilities are too numerous to
detail here, the following guidelines provide a general approach to assessing these patients:-
5. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical 
education: a cross-sectional study. Lancet. 2012 Jul 7;380(9836):37-43.
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• The driving task
First, consider the ergonomics of the driving task. How might the various impairments (sensory, cognitive and
musculoskeletal), disabilities and general fitness levels impact on function required to complete driving-related tasks?
• General functionality
Consider to what extent the person is currently able to function with regard to domestic or occupational
requirements and what compensatory or coping strategies may have been developed. Information gained from
relatives or carers is also likely to be important in this regard. Individuals may be likely to cope better with
congenital or slow-onset conditions compared with traumatic or rapidly developing conditions.  
• Clinical assessment
The key considerations are: 
- Sensory (in particular visual acuity and visual fields but also cutaneous, muscle and joint sensation). 
- Motor function (including joint movements, strength and co-ordination). 
- Cognition (including attention, concentration, presence of hallucinations and delusions, insight, judgement,
memory, problem-solving skills, thought processing and visuospatial skills). 
It may be necessary for the health professional to consider medical standards for each condition. However, it is
insufficient simply to apply the medical standards contained in this publication for each condition separately, as a
driver may have several minor impairments that alone may not affect driving but when taken together may make
risks associated with driving unacceptable. It will, therefore, be necessary to integrate all clinical information,
bearing in mind the additive or compounding effect of each condition on the overall capacity of the patient to control
the vehicle, and to act and react in an appropriate and timely way to emergent traffic and road conditions. 
• Capacity to learn to drive
Young people with multiple disabilities may seek the opportunity to gain a driving licence. In order to ensure they
receive informed advice and reasonable opportunities for training, it is helpful if they are trained by a driving
instructor with experience in the area of teaching drivers with disabilities.  
• Occupational therapy assessment
A referral for an assessment by a generalist occupational therapist may be useful. It could request an evaluation 
of overall functioning (personal, mobility, community and work activities) as well as seek an opinion on general
capacity for driving. 
• On-road driving assessment
An on-road assessment may also be helpful.
In light of the information given above, the health professional may advise the patient regarding their fitness to
drive and provide advice to the Driving Licensing Authority. The key question is: Is there a likelihood the person will
be unable to control the vehicle and act or react appropriately to the driving environment in a safe, consistent and
timely manner?
Where one or more conditions are progressive, it may be important to reduce driving exposure and ensure ongoing
monitoring of the patient. The requirement for periodic reviews can be included as recommendations. This is also
important for drivers with conditions likely to be associated with future reductions in insight and self-regulation. If
lack of insight may become an issue in the future, it is important to advise the patient to report the condition(s) to
the Driving Licensing Authority.  
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3.6 Progressive disorders
Often diagnoses of progressive disorders are made well before there is any need to question whether the patient
remains safe to drive (e.g. multiple sclerosis). However, it is advantageous to raise issues relating to the likely effects
of these disorders on personal independent mobility early in the management process.
In a mobile society, people frequently make choices about employment, place of residence and recreational and social
activities based on the assumption of continued access to a car. Changing jobs, home and social contacts takes a
great deal of time and places substantial emotional demands on patients and their families.
It is, therefore, recommended that the patient be advised appropriately where a progressive condition is diagnosed
that may result in future restrictions on driving. It is important to give the patient as much lead time as possible to
make the lifestyle changes that may later be required. Assistance from an occupational therapist may be valuable in
such instances.
3.7 Congenital conditions
People with congenital or childhood conditions may have developed coping strategies that enable safe driving despite
their impairment. They will require individual assessment by a specialist and may need tutoring prior to a practical
assessment. While they may require specific vehicle modifications, if the condition is static they may not require
periodic reviews. 
3.8 Medications and driving
Any medication that acts on the central nervous system has the potential to adversely affect driving skills, although 
it must be also recognised that many medications, such as anti-parkinsonian medications, anti-inflammatory agents
and anti-depressants, may actually make driving safer and more comfortable. 
Central nervous system depressants, for example, may reduce vigilance, increase reaction times and impair decision-
making in a very similar manner to alcohol. In addition, medications that affect behaviour may exaggerate adverse
behavioural traits and introduce risk-taking behaviours. 
Acute impairment due to alcohol or drugs (including illicit, prescription and over–the-counter drugs) is managed
through specific road safety legislation that prohibits driving over a certain blood alcohol concentration (BAC) or
when impaired by drugs. This is a separate consideration to long-term medical fitness to drive and licensing, thus
specific medical requirements are not provided in this publication. Dependency and substance misuse, including
chronic misuse of prescription drugs, is a licensing issue and standards are outlined in Chapter 6. 
Where medication is relevant to the overall assessment of fitness to drive in the management of specific conditions,
The definition of prescription medications for the purpose of these guidelines is recommended as: Licensed
medical product for human use requiring to be used in accordance with a prescription or medical product for
human use requiring it to be used in accordance with prescription or medical or healthcarer (including
pharmacist) advice.
RSA COVERS_body text  19/12/2012  10:10  Page 13
such as diabetes, epilepsy and psychiatric conditions, this is covered in the respective chapters. Prescribing doctors
and dispensing pharmacists do, however, need to be mindful of the potential effects of all prescribed and over-the-
counter medicines and to advise patients accordingly.  General guidance is provided below.
3.8.1 General guidance for prescription medicine and driving
While many medicines have effects on the central nervous system most, with the exception of benzodiazepines, tend
not to pose a significantly increased crash risk when the medicines are used as prescribed, and once the patient is
stabilised on the treatment. This may also relate to drivers’ self-regulating their driving behaviour. When advising
patients and considering their general fitness to drive, whether in the short or longer term, health professionals
should consider the following:
• The balance between potential impairment due to the medicine and the patient’s improvement in health on safe
driving ability. 
• The individual response of the patient – some individuals are more affected than others. 
• The type of licence held and the nature of the driving task i.e. commercial vehicle driver assessments should be
more stringent. 
• The added risks of combining two or more medicines capable of causing impairment, including alcohol. 
• The added risks of sleep deprivation on fatigue while driving, which is particularly relevant to commercial vehicle
drivers. 
• The potential impact of changing medications or changing dosage. 
• The cumulative effects of medications. 
• The presence of other medical conditions that may combine to adversely affect driving ability. 
• Other factors that may exacerbate risks, such as known history of alcohol or drug misuse. 
Liaison between prescribing doctors and pharmacists is encouraged in the consideration of advice given to drivers
taking medications which may impact on safe driving.
3.8.2 The effects of specific medicine classes
Benzodiazepines
Benzodiazepines, particularly long-acting benzodiazepines, increase the risk of a crash. In many of these cases,
benzodiazepines were either abused or used in combination with other impairing substances. If a hypnotic is needed,
a shorter-acting medicine is preferred. Tolerance to the sedative effects of the longer-acting benzodiazepines used in
the treatment of anxiety gradually reduces their adverse impact on driving skills.
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Antidepressants
Although antidepressants are one of the more commonly detected drug groups in fatally injured drivers, this tends 
to reflect their wide use in the community. The ability to impair is greater with sedating tricyclic antidepressants,
such as amitriptyline and dosulepin, than with less sedating serotonin reuptake inhibitors, such as fluoxetine and
sertraline, and the mixed reuptake inhibitors. However, antidepressants can reduce the psychomotor and cognitive
impairment caused by depression and return mood towards normal. This can improve driving performance.
Antipsychotics
This diverse class of drugs can improve performance if substantial psychotic-related cognitive deficits are present.
However, most antipsychotics are sedating and have the potential to adversely affect driving skills through blockade
of central dopaminergic and other receptors. Older drugs such as chlorpromazine are very sedating due to their
additional actions on the cholinergic and histamine receptors. Some newer drugs are also sedating, such as clozapine,
olanzapine and quetiapine, while others such as aripiprazole, risperidone and ziprasidone are less sedating. Sedation
may be a particular problem early in treatment and at higher doses.
Opioids
There is little direct evidence that opioid analgesics such as hydromorphone, morphine or oxycodone have direct
adverse effects on driving behaviour. Cognitive performance is reduced early in treatment, largely due to their
sedative effects, but neuroadaptation is rapidly established. This means that patients on a stable dose of an opioid
may not have a higher risk of a crash. This includes patients on buprenorphine and methadone for their opioid
dependency, providing the dose has been stabilised over some weeks and they are not abusing other impairing drugs.
Driving at night may be a problem due to the persistent miotic effects of these drugs reducing peripheral vision.
4.0 The legal basis for the medical standards
The Road Safety Authority will become the licensing authority in January 2013, and will have the responsibility of
ensuring that all licence holders are fit to drive. 
The legal basis of fitness to drive arises from the Road Traffic (Licensing of Drivers) Regulations 2006, Statutory
Instrument Number 537 of 2006, as amended in 2010 and associated regulations, as well as the Directive
(91/439/EEC) on driving licences. Directive (91/439/EEC) was amended by Directive 2009/112/EC with effect from
15.9.09 and these amendments came into force in Ireland in 2010. (See table to follow).
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Table 4: Legal considerations for licensing
• Licensing Authority processes following medical advice 
Driving licences are issued or maintained by the Driving Licence Authority on the basis that driver has not been
advised to cease driving by a doctor or healthcare professional on the basis of clinical assessment and the
advice contained within these guidelines. Should a driver be advised to cease driving by a doctor or healthcare
professional on the basis of clinical assessment and the advice contained within these guidelines, he/she
should inform the Driving Licensing Authority if so indicated in these guidelines. It is then a matter for the
Driving Licensing Authority to take appropriate action.
• Appeals
Decisions about the granting of a driving licence are a matter for the Driving Licensing Authority and
arrangements concerning the review or appeal against such decisions should be taken up with the Driving
Licensing Authority.
• Age limits
Group1 Licences are normally issued for a ten-year period subject to expiry at age 70 years, unless restricted to
a shorter duration for medical reasons. There is no upper limit but after age 70 renewal is necessary every 3
years, or every year if medical assessment so indicates. All licence applications after 70 currently require a
medical report furnished by the applicant.
• Garda/Army driver licensing
Responsibility for determining the standards, including medical requirements, to be applied to Garda/Army
vehicle drivers, over and above the Group 1 driving licence requirements, rests with the Garda Commissioner/
Army Director of Services.
• Taxi drivers
The provision of driving licences for small Public Service Vehicles is the responsibility of the Garda Carriage
Office. Responsibility for determining the standards, including medical requirements, to be applied to taxi
drivers, over and above the Group 1 driving licence requirements, rests with the Garda Commissioner.
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Part B: Medical fitness to drive 
Chapter 2
Neurological disorders
Neurological Disorders Group 1 — Car, M/Cycle
Epilepsy
Epileptic attacks are the most frequent medical cause 
of collapse at the wheel.
NB: If within a 24 hour period more than one epileptic
attack occurs, these are treated as a “single event” 
for the purpose of applying the epilepsy regulations.
Epilepsy includes all events: major, minor and auras.
The epilepsy regulations apply. 
Provided a licence holder/applicant is able to satisfy the
regulations, a 3-year licence will be issued normally by
the Driving Licensing Authority. Before the age 70 a
person must be seizure-free for five years to qualify for a
ten-year licence in the absence of any other disqualifying
condition. Licence restored if seizure-free for 5 years
since the last attack, with medication if necessary in 
the absence of any other disqualifying condition. 
(See appendix to this chapter for full regulations).
Driver must notify Driving Licensing Authority.
First unprovoked epileptic seizure/solitary fit 6 months off driving from the date of the seizure unless
there are clinical factors or investigation results which, 
in the opinion of the treating specialist suggest an
unacceptably high risk of a further seizure, i.e. 20% or
greater per annum.
Driver must notify Driving Licensing Authority.
Epilepsy/epileptic seizures
General guidance for all neurosurgical conditions if
associated with epilepsy or epileptic seizures.
In all cases where epilepsy has been diagnosed, the
Epilepsy Regulations apply. These cases will include all
cases of single seizure where a primary cerebral cause 
is present and the liability to recurrence cannot be
excluded. An exception may be made when seizures
occur at the time of an acute head injury or intracranial
surgery.
Driver must notify Driving Licensing Authority.
Withdrawal of anti-epilepsy medication and driving (See Appendix to this chapter for full regulations).
Provoked seizures 
(Apart from alcohol or illicit drug misuse)
(See Appendix to this chapter for full regulations). 
See Appendix at end of this chapter for epilepsy regulations
RSA COVERS_body text  19/12/2012  10:10  Page 17
Loss of consciousness/loss of or altered awareness
Excluding Cough Syncope (See Chapter 9)
A full history is imperative to include pre-morbid history, prodromal symptoms, period of time unconscious, degree 
of amnesia and confusion on recovery. A neurological cause, for example, epilepsy, subarachnoid haemorrhage, can
often be identified by the history, examination and the appropriate referral made. The relevant Slánte agus Tiomáint
guidelines will then apply. 80% of all cases have a cardiovascular cause and again, these can be determined by
history, examination and ECG. Investigate and treat accordingly and use the relevant Slánte agus Tiomáint guidelines.
The remaining cases can be classified under five categories in the following table:
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Neurological Disorders Group 1 — Car, M/Cycle
1. Reflex Vasovagal Syncope 
Definite provocational factors with associated prodromal
symptoms and which are unlikely to occur whilst sitting
or lying. Benign in nature.
No driving restrictions.
If recurrent, will need to check the “3 Ps” apply on each
occasion (provocation/prodrome/postural).
(If not see Number 3 below).
Driving Licensing Authority need not be informed.
2. Loss of consciousness/loss of or altered awareness
likely to be unexplained syncope but with a high
probability of reflex vasovagal syncope. 
These have no clinical evidence of structural heart
disease and a normal ECG.
No driving restrictions.
Driving Licensing Authority need not be informed.
3. Loss of consciousness/loss of or altered awareness
likely to be cardiovascular in origin (Excluding 1 or 2).
Factors indicating high risk:
A. Abnormal ECG
B. Clinical evidence of structural heart disease
C. Syncope causing injury, occurring tt the wheel or
whilst sitting or lying
D. More than one episode in previous six months.
Further investigations such as ambulatory ECG (48hrs),
echocardiography and exercise testing may be indicated
after specialist opinion has been sought.
* For Pacemakers See Chapter 3
No driving for 6 months if no cause identified.
Can drive 4 weeks after the event if the cause has been
identified and treated.
Driver must notify Driving Licensing Authority.
See Appendix at end of this chapter for epilepsy regulations
RSA COVERS_body text  19/12/2012  10:10  Page 18
Sláinte agus Tiomáint | Medical Fitness To Drive Guidelines |  (Group 1 Drivers) 19
Údarás Um Shábháilteacht Ar Bhóithre
Road Safety Authority
Neurological Disorders Group 1 — Car, M/Cycle
4. Presumed loss of consciousness/loss of or altered
awareness with seizure markers
This category is for those where there is a strong clinical
suspicion of a seizure but no definite evidence.
Factors to be considered:
• Unconsciousness For More Than 5 Minutes.
• Amnesia Longer Than 5 Minutes
• Injury
• Tongue Biting
• Incontinence
• Remain Conscious But With Confused Behaviour
• Headache Post Attack
6 months off driving from the date of an episode of loss
of consciousness/loss of or altered awareness.
However, if a person has a previous history of epilepsy or
a solitary seizure, 12 months’ freedom from any further
episode of loss of consciousness with seizure markers
must be attained.
If a person suffers recurrent episodes of loss of
consciousness with seizure markers, 12 months’ 
freedom from such episodes must be attained.
Driver must notify Driving Licensing Authority.
5. Loss of consciousness/loss of or altered awareness
with no clinical pointers.
This category will have had appropriate neurological 
and cardiac opinion and investigations but with no
abnormality detected.
No driving for 6 months
Driver must notify Driving Licensing Authority.
Primary/Central Hypersomnias
Including Narcoleptic syndromes
Cease driving on diagnosis.
Driving may resume when there has been a period of
between 3 and 6 months satisfactory control of symptoms
with appropriate treatment.If not on appropriate
treatment, driving may be allowed subject to a
satisfactory objective assessment of maintained
wakefulness, such as the Osler test.
Driver must notify Driving Licensing Authority if driving
cessation is going to be 6 months or greater.
Chronic Neurological Disorders 
E.g. Multiple sclerosis, motor neurone disease, etc.,
which may affect vehicle control because of impairment
of co-ordination and muscle power. 
See also Appendix 1 for information on Driving
assessment for “disabled drivers”.
Providing medical assessment confirms that driving
performance is not impaired, can drive. A 1 or 3 year
licence may be advised. Should the driver require a
restriction to certain controls, the law requires this to be
specified on the licence. Due consideration should be
given to rehabilitation, specialist on-road assessment
and adaptations which may help to adapt to, or
overcome, relevant cognitive and physical impairment.
Driver must notify Driving Licensing Authority.
Parkinson’s disease and other forms of Parkinsonism Should not drive if condition or functional status is
sufficiently impaired so as to impair driving safety and/or
there is clinically significant variability in motor function.
Due consideration should be given to medication review
(with due attention to tendency to drowsiness/sleepiness),
rehabilitation, specialist on-road assessment and
adaptations which may help to adapt to, or overcome,
relevant cognitive and physical impairment. If driving
safety not impaired, can continue driving subject to
satisfactory reports. Fitness to drive is subject to regular
review.
Driver must notify Driving Licensing Authority.
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Neurological Disorders Group 1 — Car, M/Cycle
Liability to sudden attacks of unprovoked or
unprecipitated disabling dizziness
Cease driving on diagnosis. Driving will be permitted
when satisfactory control of symptoms achieved. 
If remains asymptomatic a ten year licence or if over 
60 a licence expiring at age 70, can be issued. After age
70 a one or three year licence, subject to medical report,
can be issued. 
Stroke/TIA TIA
NO need to notify Driving Licensing Authority
Must not drive for 1 month.
STROKE
Must not drive for 1 month. May resume driving after
this period if the clinical recovery is satisfactory. There is
no need to notify Driving Licensing Authority unless
there is significant residual neurological deficit 1 month
after the episode; of particular importance are visual
field defects, cognitive defects including visual neglect
and inattention and impaired limb function. Minor limb
weakness alone will not require notification unless
restriction to certain types of vehicle or vehicles with
adapted controls is needed. Due consideration should be
given to rehabilitation, specialist on-road assessment
and adaptations which may help to adapt to, or
overcome, relevant cognitive and physical impairment.
Seizures occurring at the time of a stroke/TIA or in 
the ensuing 24 hours may be treated as provoked for
licensing purposes in the absence of any previous seizure
history or previous cerebral pathology. Seizures
occurring at the time of intracranial venous thrombosis
require 6 months free from attacks before resuming driving.
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Acute Encephalitic Illnesses and Meningitis 1.   If no seizure(s), may resume driving when clinical
recovery is complete. (The driver need notify Driving
Licensing Authority only if there is significant
residual disability).
2.   If associated with seizures during acute febrile
illness, no driving for 6 months from the date of
seizure(s). Driver must notify Driving Licensing
Authority.
3.   If associated with seizure(s) during or after
convalescence, will be required to meet epilepsy
regulations.
Transient Global Amnesia Provided epilepsy, any sequelae from head injury and
other causes of altered awareness have been excluded,
no restriction on driving.  
Driving Licensing Authority need not be notified.  
Arachnoid Cysts
Asymptomatic and untreated
Craniotomy and/or Endoscopic Treatment
No restriction.
6 months off driving.
Driver must notify Driving Licensing Authority.
Colloid Cysts
Asymptomatic and untreated.
Craniotomy and/or Endoscopic Treatment
No restriction.
6 months off driving.
Driver must notify Driving Licensing Authority.
Pituitary Tumour
Craniotomy
Provided no visual field defect.
(If visual field loss, see Vision section)
6 months off driving.
Driver must notify Driving Licensing Authority.
Transphenoidal surgery/other treatment 
(E.g., Drugs, Radiotherapy) or Untreated
Drive on recovery.
See Appendix at end of this chapter for epilepsy regulations
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Benign Supratentorial Tumour
E.g. Who Grade 1 Meningiomas 
Treatment by Craniotomy
6 months off driving when there is no debarring 
residual impairment likely to affect safe driving. 
Driver must notify Driving Licensing Authority.
Epilepsy regulations apply if relevant history of seizure(s).
Treatment with Stereotactic Radiosurgery 1 month off driving; can drive when there is no debarring
residual impairment likely to affect safe driving. 
Driver must notify Driving Licensing Authority.
Epilepsy regulations apply if relevant history of seizure(s).
Treatment with Fractionated Radiotherapy Can drive on completion of treatment, provided that
there is no debarring residual impairment likely to affect
safe driving.
Epilepsy regulations apply if relevant history of seizure(s).
Who Grade I Meningiomas treated by Craniotomy
and/or Radiosurgery and/or Radiotherapy
Asymptomatic, incidental meningiomas: Untreated
Requires 1 year off driving, dating from the completion
of treatment. 
Driver must notify Driving Licensing Authority.
Epilepsy regulations apply if relevant history of seizure(s).
Continue driving.
Benign Infratentorial Tumours 
E.g. Meningioma with surgery by craniotomy with or
without radiotherapy.
Acoustic Neuroma/Schwannoma
Drive on recovery.
Need not notify Driving Licensing Authority unless
sudden and disabling giddiness.
Malignant Tumours (including metastatic deposits)  
and Gliomas
Supratentorial 
Grades 1 and II gliomas
1 year off driving, from time of completion of the
primary treatment. 
Driver must notify Driving Licensing Authority.
WHO Grade III Meningioma 2 years off driving from time of completion of primary
treatment.
Driver must notify Driving Licensing Authority.
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Grades III and IV Gliomas and Metastatic Deposit(s) At least 2 years off driving from time of completion of
primary treatment.
Driver must notify Driving Licensing Authority.
Solitary Metastatic Deposit If totally excised, can be considered for recommending 
1 year licence after completion of primary treatment if
free from recurrence and no evidence of secondary
spread elsewhere in the body.
Driver must notify Driving Licensing Authority.
Infratentorial Tumours
Grade 1
As for benign tumours: i.e. drive on recovery.
Grades II, III & IV As for Supratentorial tumour
Medulloblastoma or Low Grade Ependymoma If totally excised, can be considered for 1 year licence
after primary treatment, if free from recurrence.
High Grade Ependymomas, other Primary Malignant
Brain Tumours
Normally, a period of 2 years off driving is required
following treatment.
Driver must notify Driving Licensing Authority.
Metastatic Deposits Can be considered for driving on a 1 year licence after
completion of primary treatment if otherwise well.
Driver must notify Driving Licensing Authority.
Malignant Intracranial Tumours in children who survive
to adult life without recurrence
Normally, till 70 licence is issued/maintained.
When a low grade glioma is an incidental finding and asymptomatic, the case may be considered on an
individual basis for Group 1.
See Appendix at end of this chapter for epilepsy regulations
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Significant head injury Usually requires 6—12 months off driving depending on
features such as seizures, post-traumatic amnesia, dural
tear, haematoma and contusions. There will need to
have been a satisfactory clinical recovery and in
particular no visual field defect, or cognitive impairment
likely to affect safe driving. Due consideration should be
given to rehabilitation, specialist on-road assessment
and adaptations which may help to adapt to, or
overcome, relevant cognitive and physical impairment.
Driver must notify Driving Licensing Authority.
Spontaneous Acute Subdural Haematoma
(Treated by Craniotomy)
6 months off driving if no significant residual disability. 
If significant residual disability, due consideration should
be given to rehabilitation, specialist on-road assessment
and adaptations which may help to adapt to, or
overcome, relevant cognitive and physical impairment. 
Driver must notify Driving Licensing Authority.
Chronic Subdural
(Treated surgically)
Resume driving on recovery if no significant residual
disability. If significant residual disability, due
consideration should be given to rehabilitation,
specialist on-road assessment and adaptations which
may help to adapt to, or overcome, relevant cognitive
and physical impairment.
Driver must notify Driving Licensing Authority.
Subarachnoid Haemorrhage 
1. No cause found
Provided comprehensive cerebral angiography normal,
may resume driving following recovery if no significant
residual disability. If significant residual disability, 
due consideration should be given to rehabilitation,
specialist on-road assessment and adaptations which
may help to adapt to, or overcome, relevant cognitive
and physical impairment.
Driver must notify Driving Licensing Authority.
2. Due to Intracranial Aneurysm
A. Surgery Craniotomy
Anterior or Posterior Cerebral Aneurysm. 
With no deficit
Driving permitted when clinically recovered from
craniotomy.
Driver must notify Driving Licensing Authority.
With deficit 6 months off driving and then can drive thereafter if no
complications. 
Driver must notify Driving Licensing Authority.
See Appendix at end of this chapter for epilepsy regulations
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Middle Cerebral Aneurysm
With no deficit
6 months off driving, and then can drive thereafter if no
significant complications. 
Driver must notify Driving Licensing Authority.
With deficit 1 year off driving after craniotomy if no significant
residual disability. If significant residual disability,
due consideration should be given to rehabilitation,
specialist on-road assessment and adaptations which
may help to adapt to, or overcome, relevant cognitive
and physical impairment.  
Driver must notify Driving Licensing Authority.
B. Endovascular treatment Cease driving until clinically recovered. 
Driver must notify Driving Licensing Authority.
C. No treatment
i.e. Aneurysm responsible for SAH but no intervention
6 months off driving after diagnosis then till can drive
thereafter if no significant complications.
Driver must notify Driving Licensing Authority.
D. Truly incidental
Findings of Intracranial Aneurysm
(Aneurysm has not been responsible for subarachnoid
haemorrhage).
No treatment No restriction.
Surgery Craniotomy Resume driving on recovery.
Endovascular treatment Cease driving until clinical recovery.
Endovascular treatment Cease driving until clinically recovered.  
Driver must notify Driving Licensing Authority.
See Appendix at end of this chapter for epilepsy regulations
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Arteriovenous Malformation
Supratentorial AVMS
Intracerebral Haemorrhage due to Supratentorial AVM
A. Craniotomy
6 months off driving; can drive thereafter when there
is no debarring residual impairment likely to affect 
safe driving. If significant residual disability, due
consideration should be given to rehabilitation,
specialist on-road assessment and adaptations which
may help to adapt to, or overcome, relevant cognitive
and physical impairment. 
Driver must notify Driving Licensing Authority.
B. Other treatment (Embolisation or Stereotactic
Radiotherapy)
1 month off driving; can drive thereafter when there is no
debarring residual impairment likely to affect safe driving.
C. No treatment As above.
Incidental finding of a supratentorial AVM
(no history of Intracranial Bleed)
A. No treatment No restriction.
B. Surgical or other treatment See Above: As for AVM with Intracranial Haemorrhage
Infratentorial AVMS
Intracranial haemorrhage due to AVM:
A. Treated by Craniotomy Can drive when there is no debarring residual
impairment likely to affect safe driving.
B. Embolisation/Stereotactic Radiotherapy As above.
C. No treatment As above.
See Appendix at end of this chapter for epilepsy regulations
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Incidental finding of an Infratentorial AVM
A. No treatment
B. Surgical or other treatment
No restriction
Can drive when there is no debarring residual
impairment likely to affect safe driving.
DURAL AV FISTULA Continued driving subject to individual assessment.
Cavernous Malformation
Supratentorial
A. Incidental No restriction.
B. Seizure, no surgical treatment Epilepsy regulations apply if history of seizure(s).
C. Haemorrhage and/or focal neurological deficit, 
no surgical treatment
Epilepsy regulations apply if history of seizure(s).
D. Treated by Surgical Excision (Craniotomy) Can drive when there is no debarring residual
impairment likely to affect safe driving. If significant
residual disability, due consideration should be given 
to rehabilitation, specialist on-road assessment and
adaptations which may help to adapt to, or overcome,
relevant cognitive and physical impairment 
Driver must notify Driving Licensing Authority.
Epilepsy regulations apply if history of seizure(s).
E. Treated by radiosurgery irrespective of whether
incidental or symptomatic.
6 months off; can drive when there is no debarring
residual impairment likely to affect safe driving
Epilepsy regulations apply if history of seizure(s).
Driver must notify Driving Licensing Authority.
No restriction.
Epilepsy regulations apply if history of seizure(s).
Infratentorial
A. Incidental
No restriction.
B. With Focal Neurological Deficit or Haemorrhage Can drive when there is no debarring residual
impairment likely to affect safe driving.
Epilepsy regulations apply if history of seizure(s).
C. Treated By Surgical Excision (Craniotomy) As above.
NB. Multiple Cavernoma: no firm evidence of↑morbidity
Size is not an issue
See Appendix at end of this chapter for epilepsy regulations
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Intracerebral Abscess/Subdural Empyema One year off driving.  
Driver must notify Driving Licensing Authority.
Hydrocephalus If uncomplicated, can be recommended for continued
driving. 
Intraventricular Shunt or Extraventricular Drain
Insertion or revision of upper end of ventricular shunt 
or extra-ventricular drain.
6 months off driving. Can be recommended for
continued driving thereafter when there is no debarring
residual impairment likely to affect safe driving.
Driver must notify Driving Licensing Authority.
Neuroendoscopic procedures 
Eg. IIIrd Ventriculostomy
6 months off. Can be recommended for continued 
driving thereafter when there is no debarring 
residual impairment likely to affect safe driving. 
Driver must notify Driving Licensing Authority.
Intracranial Pressure Monitoring Device
Inserted by Burr Hole Surgery.
The prospective risk from the underlying condition must
be considered.
Implanted Electrodes
Deep brain stimulation for movement disorder or pain
If no complications from surgery and seizure, can drive
when there is no debarring residual impairment likely to
affect safe driving
Driver must notify Driving Licensing Authority.
Implanted Motor Cortex stimulator for pain relief If aetiology of pain is non-cerebral e.g. trigeminal
neuralgia, 6 months off. If the aetiology is cerebral e.g.
stroke, 12 month off. Can then drive when there is no
debarring residual impairment likely to affect safe driving.
See Appendix at end of this chapter for epilepsy regulations
RSA COVERS_body text  19/12/2012  10:10  Page 28
Appendix — Chapter 2
Epilepsy regulations for Group 1
This means that:
1. A person who has suffered an epileptic attack whilst awake must refrain from driving for at least one year from
the date of the attack: driving cannot resume until the driver has had no further seizures while awake for a 
12-month period.
2. A person who has experienced seizures exclusively while asleep may be considered for a one year licence despite
continuing seizures only during sleep, and subject to at least annual review, taking into account information
provided by the treating doctor (with appropriate expertise and due consultation as required) as to whether the
following criteria are met:
• There have been no previous seizures while awake; and 
• The first sleep-only seizure was at least 12 months ago; and 
• The person follows medical advice, including adherence to medication if prescribed. 
or
• There have been previous seizures while awake but not in the preceding one year; and 
• Sleep-only seizures have been occurring for at least one year; and 
• The person follows medical advice, including adherence to medication if prescribed. 
and in both cases
3. I. So far as practicable, the person complies with advised treatment and check-ups for epilepsy, and 
II. The driving of a vehicle by such a person should not be likely to cause danger to the public.  
A specific exception to these are seizures a judged by the treating consultant neurologist as not impairing
consciousness or driving ability at any time. An annual licence may be granted by the Driving Licensing Authority
subject to at least annual review, taking into account information provided by the treating consultant as to whether
the following criteria are met:
• Seizures not impairing consciousness or driving ability at any time have been present for at least one year; and 
• There have been no seizures of other type for at least one year; and 
• The person follows medical advice, including adherence to medication if prescribed. 
Guidance for clinicians advising patients to cease driving in the case of break-through
seizures in those with established epilepsy
In the event of a seizure, the patient must be advised not to drive unless they are able to meet the conditions of 
the asleep concessions. The patient must be advised to notify their Driving Licensing Authority. In exceptional cases 
(e.g. seizure secondary to prescribing error), a specialist may advise a return after a shorter period.
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Guidance for withdrawal of anti-epilepsy medication being withdrawn on specific
medical advice
(N.B. This advice only relates to treatment for epilepsy)
From a medico-legal point of view, the risk of further epileptic seizures occurring during this therapeutic procedure
should be noted. If an epileptic seizure does occur, the patient will need to satisfy driving licence regulations before
resuming driving and will need to be counselled accordingly. The current Epilepsy Regulations require a period of at
least one year free of any manifestation of epileptic seizure or attacks whilst awake from the date of the last attack;
special consideration is given where attacks have occurred only whilst asleep.
It is clearly recognised that withdrawal of anti-epilepsy medication is associated with a risk of seizure recurrence. 
A number of studies have shown this, including the randomised study of anti-epilepsy drug withdrawal in patients in
remission, conducted by the Medical Research Council Anti-epileptic Drug Withdrawal Study Group. This study shows
a 40% increased associated risk of seizure in the first year of withdrawal of medication compared with those who
continued on treatment.
Patients undergoing withdrawal of anti-epilepsy medications should be warned of the risk they run, both of needing
to cease driving and also of having a seizure which could result in a road traffic accident. Patients should be advised
not to drive from commencement of the period of withdrawal and thereafter for a period of 6 months after cessation
of treatment. A person remains as much at risk of seizure associated with drug withdrawal during the period of
withdrawal as in the 6 months after withdrawal. 
This advice may not be appropriate in every case. One specific example is withdrawal of anticonvulsant medication
when there is a well-established history of seizures only while asleep. In such cases, any restriction in driving is best
determined by the specialist concerned, after considering the history. It is up to the patient to comply with such advice.
It is important to remember that the epilepsy regulations are still relevant even if epileptic seizures occur after
medication is omitted, for example on admission to hospital for any condition. 
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Provoked seizures
Provoked or acute symptomatic seizures may be dealt with on an individual basis if there is no previous seizure
history. Seizures associated with alcohol or drug misuse, sleep deprivation or a structural abnormality are not
considered provoked for licensing purposes. Similarly, reports of seizures as a side-effect of prescribed medication
do not automatically imply that such events should be considered as provoked. For seizure(s) with alcohol or illicit
drugs, please see relevant section in the booklet.
Doctors may wish to advise patients that the period of time likely to be recommended off driving will be influenced
inter alia by:
A. Whether it is clear that the seizure had been provoked by a stimulus which does not convey any risk of recurrence
and does not represent an unmasking of an underlying liability; and
B. Whether the stimulus had been successfully/appropriately treated or is unlikely to occur at the wheel.
In the absence of any previous seizure history or previous cerebral pathology, the following seizures may also be
treated as provoked: 
• Eclamptic Seizures
• Reflex Anoxic Seizures
• An Immediate Seizure (within seconds) at the time of a head injury 
• Seizure in first week following a head injury (see head injury section) at the time of a Stroke/TIA or within the
ensuing 24 hours
• During intracranial surgery or in the ensuing 24 hours.
Seizures occurring during an acute exacerbation of multiple sclerosis or migraine will need to be assessed on an
individual basis by a specialist.
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Cardiovascular disorder
A licence holder or applicant must meet the standards for cardiovascular disorder outlined below, and if there is
reason to doubt that these are met, the applicant or licence holder should undergo a more detailed examination 
by a specialist — see Appendix to this chapter.
Cardiovascular Disorders Group 1 Entitlement ODL — Car, M/Cycle
Angina Driving must cease when symptoms occur at rest, with
emotion, or at the wheel
Driving may recommence when satisfactory symptom
control is achieved.
Driving Licensing Authority need not be notified.
Acute Coronary Syndromes (ACS) defined as:
1.   Unstable angina (symptoms at rest with ECG changes)
2.   Non STEMI with at least two of the following criteria
• Symptoms at rest
• Raised Serum Troponin 
• ECG changes
3. STEMI symptoms with ST elevation on ECG
If successfully treated by coronary angioplasty, driving
may recommence after 1/52 provided:
• No other URGENT revascularisation is planned.
(URGENT refers to within 4/52 from acute event)
• LVEF is at least 40% prior to hospital discharge.
• There is no other disqualifying condition.
If not successfully treated by coronary angioplasty,
driving may recommence after 4/52 provided:
• There is no other disqualifying condition.
Driving Licensing Authority need not be notified.
Percutaneous Coronary Intervention
(Angioplasty ± stent)
Elective
*Driving must cease for at least 2 days
Driving may recommence thereafter provided there is no
other disqualifying condition. 
Driving Licensing Authority need not be notified.
CABG Driving must cease for at least 4/52
Driving may recommence thereafter provided there is no
other disqualifying condition. 
Driving Licensing Authority need not be notified.
See Appendix at end of this chapter 
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Arrhythmia
Sinoatrial disease
Significant atrio-ventricular conduction defect
Atrial flutter/fibrillation
Narrow or broad complex tachycardia
(See also following sections —Pacemakers are
considered separately)
NB: Transient Arrhythmias occurring during acute
Coronary Syndromes do not require assessment under
this Section.
Driving must cease if the arrhythmia has caused or is
likely to cause incapacity.
Driving may be permitted when underlying cause has
been identified and controlled for at least 4/52.
Driving Licensing Authority  need not be notified unless
there are distracting/disabling symptoms.
Successful Catheter Ablation Driving must cease for at least 2/7.
Driving may be permitted thereafter provided there is no
other disqualifying condition.
Driving Licensing Authority  need not be notified.
Pacemaker Implant
Includes box change
Driving must cease for at least 1/52.
Driving may be permitted thereafter provided there is no
other disqualifying condition.
Unpaced Congenital Complete Heart Block May drive if asymptomatic.
Atrial Defibrillator
Physician/Patient Activated
Driving may continue provided there is no other
disqualifying condition.
Driver must notify Driving Licensing Authority.
Atrial Defibrillator
Automatic
Driving may continue provided there is no other
disqualifying condition.
See also ICD Section
See Appendix at end of this Chapter 
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Implantable Cardioverter Defibrillator (ICD) 
Implanted for ventricular arrhythmia associated with
incapacity
Patients with ICDs implanted for sustained ventricular
arrhythmias should not drive for:
1. A period of 6/12 after the first implant.
2. A further 6/12 after any shock therapy and/or
symptomatic antitachycardia pacing (see 3A below). 
3A. A period of 2 years if any therapy following device
implantation has been accompanied by incapacity
(whether caused by the device or arrhythmia), except as
in 3B and 3C.
3B. If therapy was delivered due to an inappropriate
cause, i.e. a trial fibrillation or programming issues, then
driving may resume 1/12 after this has been completely
controlled to the satisfaction of the cardiologist.
Driving Licensing Authority  need not be notified.
3C. If the incapacitating shock was appropriate (i.e. for
sustained VT or VF) and steps have been taken to prevent
recurrence, (e.g., introduction of anti-arrhythmic drugs
or ablation procedure) driving may resume after 6/12 
in the absence of further symptomatic therapy. 
For 2 and 3A/3C, if the patient has been re-licensed prior
to the event, Driver must notify Driving Licensing
Authority.
4. A period of 1/12 off driving must occur following any
revision of the electrodes or alteration of anti-arrhythmic
drug treatment.
5. A period of 1/52 off driving is required after a
defibrillator box change.
Resumption of driving requires that;
1. The device is subject to regular review with
interrogation.
4. There is no other disqualifying condition.
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Cardiovascular Disorders Group 1 Entitlement ODL — Car, M/Cycle
Implantable Cardioverter Defibrillator (ICD) 
Implanted for ventricular arrhythmia which did not
cause incapacity.
If the patient presents with a non-disqualifying cardiac
event, i.e. haemodynamically stable non-incapacitating
sustained ventricular tachycardia, the patient can drive
1/12 after ICD implantation providing all of the following
conditions are met:
• LVEF > than 35%
• No fast VT induced on electrophysiological study
(RR< 250 msec)
• Any induced VT could be pace-terminated by the ICD
twice, without acceleration, during the post
implantation study.
Driving Licensing Authority need not be notified. 
Should the ICD subsequently deliver ATP and/or shock
therapy (except during normal clinical testing) then the
licensing criteria on the previous page applies and  
Driver must notify Driving Licensing Authority.
Prophylactic ICD Implant Asymptomatic individuals with high risk of significant
arrhythmia. Driving should cease for 1/12.
Driving Licensing Authority need not be notified.
Should the ICD subsequently deliver ATP and/or shock
therapy (except during normal clinical testing) then the
licensing criteria on the previous page applies and 
Driver must notify Driving Licensing Authority.
Ascending/Descending Thoracic and 
Abdominal Aortic Aneurysm 
Driver must notify licensing authority of any aneurysm
of 6cm in diameter, despite treatment. Licensing will be
permitted subject to annual review.
Driving may continue after satisfactory medical 
(blood pressure control) or surgical treatment, without
evidence of further enlargement. There should be no
other disqualifying condition. An aortic diameter of
6.5cm or more disqualifies from driving.
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Chronic Aortic Dissection Driving may continue after satisfactory medical (blood
pressure control) or surgical treatment, unless other
disqualifying condition.  
Driving Licensing Authority need not be notified
Marfan’s Syndrome Driving Licensing Authority need not be notified unless
there is aneurysm.
Carotid Artery Stenosis 
(See also Neurological Section)
Driving Licensing Authority need not be notified
Peripheral Arterial Disease Driving may continue provided there is no other
disqualifying condition.
Driving Licensing Authority need not be notified
Hypertension Driving may continue unless treatment causes
unacceptable side effects.
Driving Licensing Authority need not be notified
Hypertrophic 
Cardiomyopathy (HCM)
(See also Arrhythmia, Pacemaker and ICD Sections)
Driving may continue provided no other disqualifying
condition.
Driving Licensing Authority need not be notified
Dilated Cardiomyopathy
(See also Arrhythmia, Pacemaker, ICD and Heart Failure
Sections)
Driving may continue provided no other disqualifying
condition.
Driving Licensing Authority need not be notified 
Arrhythmogenic Right Ventricular  
Cardiomyopathy (ARVC) and Allied Disorders
(See also Arrhythmia, Pacemaker and ICD Sections)
Asymptomatic – Driving may continue.  
Driving Licensing Authority need not be notified.
Symptomatic – Driving must cease if an arrhythmia has
caused or is likely to cause incapacity. Re/licensing may
be permitted when arrhythmia is controlled and there is
no other disqualifying condition.
Heart Failure Driving may continue provided there are no symptoms
that may distract the driver’s attention.
Driving Licensing Authority need not be notified.
See Appendix at end of this chapter 
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Left Ventricular Assist Devices Driving should cease on insertion. (Re)licensing can be
considered on an individual basis 6/12 after device
implantation.
Driver must notify Driving Licensing Authority.
Cardiac Resynchronisation Therapy (CRT)
CRT-P
CRT-D
Driving must cease for at least 1/52 following
implantation.
Driving may continue provided there are no symptoms
relevant to driving.
There is no other disqualifying condition.
Driving may be permitted provided the ICD requirements
are met.
There is no other disqualifying condition.
Heart or Heart/Lung Transplant Driving may continue provided no other disqualifying
condition.
Driving Licensing Authority need not be notified.
Heart Valve Disease
(To include surgery, ie replacement and/or repair)
Driving Licensing Authority need not be notified unless
there is aneurysm.
Driving Licensing Authority need not be notified
Congenital Heart Disease Driving may continue provided there is no other
disqualifying condition.
Following a first licence application or identification of
such a condition, specialist assessment may be required
before a licence is (re)issued. Certain conditions will
require the issue of a medical review licence for 1, 3
years in this instance driver must notify DL.
Syncope
NB: Cough Syncope. See Chapter 7
See section entitled “Loss of Consciousness” (Chapter 1)
ECG Abnormality
Suspected Myocardial Infarction
Driving may continue unless other disqualifying condition
Driving Licensing Authority need not be notified 
Left Bundle Branch Block Driving may continue unless other disqualifying condition.
Driving Licensing Authority need not be notified.
Pre-Excitation Driving may continue unless other disqualifying condition.
Driving Licensing Authority need not be notified.
See Appendix at end of this chapter 
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Group 1 entitlements
Medication
If drug treatment for any cardiovascular condition is required, any adverse effect which is likely to affect driver
performance will disqualify. 
Exercise testing
Exercise evaluation shall be performed on a bicycle* or treadmill. Drivers should be able to complete 3 stages of the
standard Bruce protocol or equivalent safely, without anti-anginal** medication for 48 hours and should remain 
free from signs of cardiovascular dysfunction, viz. angina pectoris, syncope, hypotension, sustained ventricular
tachycardia, and/or electrocardiographic ST segment shift which accredited medical opinion interprets as being
indicative of myocardial is chaemia (usually >2mm horizontal or down-sloping) during exercise or the recovery period.
In the presence of established coronary heart disease, exercise evaluation shall be required at regular intervals not to
exceed 3 years.
* Cycling for ten minutes with 20 watt increments/minute to a total of 200W
** Anti-anginal medication refers to the use of nitrates, beta-blockers, calcium channel blockers, nicorandil,
ivabradine and ranolazine prescribed for anti-anginal purposes or for other reasons e.g. cardio-protection.
NB: When any of the above drugs are being prescribed purely for the control of hypertension or an arrhythmia
then discontinuation prior to exercise testing is not required.
Should atrial fibrillation develop de novo during exercise testing, provided the individual meets all the Driving Licence
Authority exercise tolerance test criteria, the individual will be required to undergo an echocardiogram and meet the
licensing criteria, just as any individual with a pre-existing atrial fibrillation.
Chest pain of uncertain cause
Exercise testing should be carried out as above. Those with a locomotor disability who cannot comply will require
either a gated myocardial perfusion scan, stress echo study and/or specialised cardiological opinion. 
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Stress Myocardial Perfusion Scan/Stress Echocardiography
The licensing standard requires that:
1. The LVEF is 40% or more.
2. A. No more than 10% of the myocardium is affected by reversible ischaemic change on myocardial perfusion imaging.
or
B. No more than one segment is affected by reversible ischaemic change on stress echocardiography.
NB: Full details of Driving Licensing Authority protocol requirements for such tests can be obtained on request.
Coronary Angiography
The functional implication of coronary heart disease is considered to be more predictive for licensing purposes than
the anatomical findings. For this reason the exercise tolerance test and where necessary, myocardial perfusion
imaging or stress echocardiography are the investigations of relevance for licensing purposes and it is the normal
requirement that the standard of one or other of these must be met. Angiography is therefore not commissioned for
(re-) licensing purposes. When there remains conflict between the outcome of a functional test and the results of
recent angiography, such cases can be considered on an individual basis. However, (re-) licensing will not normally be
considered unless the coronary arteries are unobstructed or the stenosis is not flow limiting and the left ventricular
ejection fraction is = to or > 40%.
‘Predictive’ refers to the risk of an infarct within 1 year. Grafts are considered as ‘Coronary Arteries’.
ETT and Hypertrophic Cardiomyopathy
For the purpose of assessment of hypertrophic cardiomyopathy (HCM) cases, an exercise test falling short of 9 minutes
would be acceptable provided:
1. There is no obvious cardiac cause for stopping the test in less than 9 minutes. 
2. There is at least a 25mm Hg rise in systolic blood pressure during exercise testing.
3. Meets all other requirements as mentioned in HCM section.
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Chapter 4
Diabetes Mellitus
Failure to meet these standards or the presence of any progressive neurological disorder requires the applicant or
licence holder to inform the Driving Licensing Authority unless stated otherwise in the text.
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Diabetes Mellitus Group 1 — Car, M/Cycle
Insulin-Treated
Drivers are sent a detailed letter of explanation about
their licence and driving by Licensing Authority.
See Appendix to this chapter for a sample of this letter
(DIABINF)
Temporary Insulin Treatment 
E.g. Post-Myocardial Infarction, participants in
Oral/Inhaled Insulin Trials.
• Must have awareness of hypoglycaemia.
• Must not have had more than one episode of
hypoglycaemia requiring the assistance of another
person in the preceding twelve months.
• There must be appropriate blood glucose monitoring.
• Must not be regarded as a likely source of danger to
the public while driving.
• The visual standards for acuity and visual field must
be met.
Impaired awareness of hypoglycaemia is defined as, 
‘an inability to detect the onset of hypoglycaemia
because of a total absence of warning symptoms’. 
If meets the medical standard a 1 or 3 year licence will
be issued. 
Provided they are under medical supervision and have
not been advised by their doctor that they are at risk of
disabling hypoglycaemia, need not notify Driving
Licensing Authority. If experiencing disabling
hypoglycaemia, Driver must notify Driving Licensing
Authority.
Notify Driving Licensing Authority if treatment continues
for more than 3 months or for more than 3 months after
delivery for gestational diabetes.
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Diabetes Mellitus Group 1 — Car, M/Cycle
Managed by tablets which carry a risk of Inducing
Hypoglycaemia. This includes Sulphonylureas and
Glinides
See Appendix to this chapter for Inf188/2
Must not have had more than one episode of
hypoglycaemia requiring the assistance of another
person within the preceding 12 months. It may be
appropriate to monitor blood glucose regularly and
driver should monitor blood glucose at times relevant to
driving to enable the detection of hypoglycaemia. Must
be under regular medical review. If however there has
been a hypoglycaemic event in the preceding 12
months, Driving Licensing Authority must be notified.
Managed by tablets other than those on the previous
page or by non-insulin injectable medication
See Appendix to this chapter for INF188/2
If all the requirements set out in the attached
information on INF188/2 are met, and they are under
regular medical review, Driving Licensing Authority does
not require notification. This information leaflet can be
printed and retained for future reference. 
Alternatively, if the information indicates that medical
enquiries will need to be undertaken, Driving Licensing
Authority must be notified.
Managed by diet alone Need not notify Driving Licensing Authority unless
develop associated conditions which are relevant to safe
driving. E.g. Diabetic eye problems affecting visual acuity
or visual field or if insulin required.
Impaired awareness of Hypoglycaemia If confirmed, driving must stop. Driving may resume
provided reports show awareness of hypoglycaemia has
been regained, confirmed by consultant/GP report.
Eyesight Complications (affecting visual acuity or fields) See Section: Visual Disorders Chapter 7
Renal Disorders See Section: Renal Disorders Chapter 8
Limb Disability
E.g. Peripheral Neuropathy
See Appendix
See Appendix at end of this chapter 
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Chapter 5
Psychiatric disorders
Failure to meet these standards or the presence of any progressive disorder requires the applicant or licence holder
to inform the Driving Licensing Authority unless stated otherwise in the text.
Psychiatric Disorders Group 1 Entitlement ODL — Car, M/Cycle
Anxiety or depression
(Without significant memory or concentration problems,
agitation, behavioural disturbance or suicidal thoughts).
Driving Licensing Authority need not be notified and
driving may continue. (See note about medication in
Appendix at end of this chapter).
Driver must inform Driving Licensing Authority
if medical advice is to cease driving for six months or
longer, or if the treating doctor would not sanction a
full 10 year licence on medical grounds if licence was
being renewed at the time of consultation.
More severe anxiety states or depressive illnesses
(With significant memory or concentration problems,
agitation, behavioural disturbance or suicidal thoughts).
NB: For cases, which also involve persistent misuse of 
or dependence on alcohol/drugs, please refer to the
appropriate section of Chapter 5. Where psychiatric
illness has been associated with substance misuse,
continuing misuse is not acceptable for licensing.
Driving should cease pending the outcome of medical
enquiry. A period of stability depending upon the
circumstances will be required before driving can be
resumed. Particularly dangerous are those who may
attempt suicide at the wheel.
Driver must inform Driving Licensing Authority 
if medical advice is to cease driving for six months or
longer, or if the treating doctor would not sanction a
full 10 year licence on medical grounds if licence was
being renewed at the time of consultation.
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Psychiatric Disorders Group 1 Entitlement ODL — Car, M/Cycle
Acute Psychotic disorders of any type 
NB: For cases, which also involve persistent misuse of or
dependence on alcohol/drugs, please refer to the 
appropriate section of Chapter 5. Where psychiatric 
illness has been associated with substance misuse, 
continuing misuse is not acceptable for licensing.
Driving must cease during the acute illness. (Re)licensing
can be considered when all of the following conditions
can be satisfied:
• Has remained well and stable for at least 3 months.
• Is compliant with treatment.
• Is free from adverse effects of medication which
would impair driving.
• Subject to a favourable specialist report.
Drivers who have a history of instability and/or poor
compliance will require a longer period off driving.
Driver must inform Driving Licensing Authority if
medical advice is to cease driving for 6 months or
longer, or if the treating doctor would not sanction a
full 10 year licence on medical grounds if licence was
being renewed at the time of consultation.
Hypomania/Mania
NB: For cases, which also involve persistent misuse of or
dependence on alcohol/drugs, please refer to the
appropriate section of Chapter 5. Where psychiatric
illness has been associated with substance misuse,
continuing misuse is not acceptable for licensing.
Driving must cease during the acute illness. Following an
isolated episode, resumption of driving can be considered
when all the following conditions can be satisfied:
A. Has remained well and stable for at least 3 months.
B. Is compliant with treatment.
C. Has regained insight.
D. Is free from adverse effects of medication which 
would impair driving.
E. Subject to a favourable specialist report.
Driver must inform Driving Licensing Authority
if medical advice is to cease driving for 6 months or
longer, or if the treating doctor would not sanction a
full 10 year licence on medical grounds if licence was
being renewed at the time of consultation.
Repeated changes of mood: Hypomania or mania are
particularly dangerous to driving when there are
repeated changes of mood. Therefore, when there have
been 4 or more episodes of mood swing within the
previous 12 months, at least 6 months stability will be
required under condition (A), in addition to satisfying
conditions (B) to (E).
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Psychiatric Disorders Group 1 Entitlement ODL — Car, M/Cycle
Chronic Schizophrenia and other Chronic Psychoses
NB: For cases, which also involve persistent misuse of or
dependence on alcohol/drugs, please refer to the
appropriate section of Chapter 5 Where psychiatric
illness has been associated with substance misuse,
continuing misuse is not acceptable for licensing.
The driver must satisfy all the following conditions:
A. Stable behaviour for at least 3 months.  
B. Is adequately compliant with treatment.
C. Remain free from adverse effects of medication,
which would impair driving.
D. Subject to a favourable specialist report.
Continuing symptoms: Even with limited insight, these
do not necessarily preclude licensing. Symptoms should
be unlikely to cause significant concentration problems,
memory impairment or distraction whilst driving.
Particularly dangerous, are those drivers whose
psychotic symptoms relate to other road users. 
Driver must inform Driving Licensing Authority
if medical advice is to cease driving for six months or
longer, or if the treating doctor would not sanction a
full 10 year licence on medical grounds if licence was
being renewed at the time of consultation. 
Developmental disorders 
Includes: Asperger’s Syndrome, autism, severe
communication disorders and Attention Deficit
Hyperactivity Disorder.
A diagnosis of any of these conditions is not in itself a
bar to licensing. Factors such as impulsivity, lack of
awareness of the impact of own behaviours on self or
others need to be considered
See Appendix at end of this chapter 
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Psychiatric Disorders Group 1 Entitlement ODL — Car, M/Cycle
Mild Cognitive Impairment (MCI) Where there is no objective impairment of function 
MCI does not need to be notified to Driving Licensing
Authority. Where there is objective impairment of
function or specific treatment is required then MCI will
not be the cause and notification must be made to the
Driving Licensing Authority.
Driver must inform Driving Licensing Authority
if medical advice is to cease driving for six months or
longer, or if the treating doctor would not sanction a
full 10 year licence on medical grounds if licence was
being renewed at the time of consultation.
Dementia or any Organic Brain Syndrome It is extremely difficult to assess driving ability in those
with dementia. Those who have poor short-term
memory, disorientation, lack of insight and judgement
are almost certainly not fit to drive.
The variable presentations and rates of progression are
acknowledged. Disorders of attention will also cause
impairment. A decision regarding fitness to drive is
usually based on medical reports.
In early dementia when sufficient skills are retained and
progression is slow, a licence may be issued subject to
annual review. A formal driving assessment may be
necessary.
Driving Licensing Authority must be notified.
Learning disability
Severely below average general intellectual functioning
accompanied by significant limitations in adaptive
functioning in at least 2 of the following areas:
communication, self-care, home-living, social/
interpersonal skills, use of community resources, 
self-direction, functional academic skills, work, leisure,
health and safety.
Severe learning disability is not compatible with driving
and the licence application must be refused. In milder
forms, provided there are no other relevant problems, it
may be possible to hold a licence, but it will be necessary
to pass the theory test and demonstrate adequate
functional ability at the wheel.
See Appendix at end of this chapter 
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Psychiatric Disorders Group 1 Entitlement ODL — Car, M/Cycle
Behaviour disorders 
includes post head injury syndrome and Non-Epileptic
Seizure Disorder
If seriously disturbed e.g. violent behaviour or alcohol
abuse and likely to be a source of danger at the wheel,
driving must cease. After medical assessment reports
confirm that behavioural disturbances have been
satisfactorily controlled, driving can resume. 
Driving Licensing Authority must be notified.
Personality disorders If likely to be a source of danger at the wheel driving
must cease. Licensing would be permitted providing
medical enquiry confirms that any behaviour disturbance
is not related to driving or not likely to adversely affect
driving or road safety.
Driver must notify Driving Licensing Authority
if medical advice is to cease driving for six months or
longer, or if the treating doctor would not sanction a
full 10 year licence on medical grounds if licence was
being renewed at the time of consultation. 
See Appendix at end of this chapter 
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Appendix 5
Psychiatric notes
Important Notes
Other psychiatric conditions, which do not fit neatly into the aforementioned classification will need to be reported
to Driving Licensing Authority if causing or felt likely to cause symptoms affecting safe driving. These would include
for example any impairment of consciousness or awareness, any increased liability to distraction or symptoms
affecting the safe operation of vehicle controls. The patient should be advised to declare both the condition and
symptoms of concern.
It is the relationship of symptoms to driving that is of importance.
• Directive (91/439/EEC) as amended by Directive 2009/112/EC requires member states to set minimum medical
standards of fitness to drive and sets out the requirements for mental health in broad terms.
• Theses Directives make a clear distinction between the standards needed for Group 1 (car and motor cycles) and
Group 2 (lorries and buses) licences. The standards for the latter being more stringent due to the size of vehicle
and the greater time spent at the wheel during the course of the occupation.
• Severe mental disorder for the purposes of these guidelines has defined as including mental illness, arrested or
incomplete development of the mind, psychopathic disorder or severe impairment of intelligence or social
functioning. The standards must reflect, not only the need for an improvement in the mental state, but also a
period of stability, such that the risk of relapse can be assessed should the patient fail to recognise any deterioration.
• Misuse of or dependence on alcohol or drugs will require the standards in this chapter to be considered in
conjunction with those of Chapter 5 of this publication.
Medication
• Any person who is driving or attempting to drive on the public highway, or other public place whilst unfit due to
any drug, is liable to prosecution (as set out under Section 4 and Section 5 of the Road Traffic Act, 2010). 
• All drugs acting on the central nervous system can impair alertness, concentration and driving performance. 
This is particularly so at initiation of treatment, or soon after and when dosage is being increased. Driving must
cease if adversely affected.
• The older tricyclic antidepressants can have pronounced anticholinergic and antihistaminic effects, which may
impair driving. The more modern antidepressants may have fewer adverse effects. These considerations need to
be taken into account when planning the treatment of a patient who is a professional driver.
• Anti-psychotic drugs, including the depot preparations, can cause motor or extrapyramidal effects as well as
sedation or poor concentration, which may, either alone or in combination, be sufficient to impair driving.
Careful clinical assessment is required.
• The epileptogenic potential of psychotropic medication should be considered particularly when patients are
professional drivers.
• Benzodiazepines are the most likely psychotropic medication to impair driving performance, particularly the long
acting compounds. Alcohol will potentiate the effects.
• Doctors have a duty of care to advise their patients of the potential dangers of adverse effects from medication
and interactions with other substances, especially alcohol.
• Drivers with psychiatric illnesses are often safer when well and on regular psychotropic medication than when
they are ill. Inadequate treatment or irregular compliance may render a driver impaired by both the illness and
medication.
Confidentiality
See Part A, Introduction Chapter 1, Section 2.3.1 
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Chapter 6
Drug and alcohol misuse and dependence
The presence of any of the conditions listed below requires the applicant or licence holder to inform the Driving
Licensing Authority unless stated otherwise in the text.
Alcohol Problems Group 1 — Car, M/Cycle
Alcohol misuse
There is no single definition which embraces all the
variables in this condition but the following is offered 
as a guide:
“A state which, because of consumption of alcohol,
causes disturbance of behaviour, related disease or other
consequences, likely to cause the patient, his/her family
or society harm now, or in the future, and which may or
may not be associated with dependence”. 
Reference to ICD10 F10.1 is relevant.
Persistent alcohol misuse, confirmed by medical enquiry
and/or by evidence of otherwise unexplained abnormal
blood markers, requires cessation from driving until a
minimum six month period of controlled drinking or
abstinence has been attained, with normalisation of
blood parameters.
Patient to seek advice from medical or other sources
during the period off the road.
Driver must notify Driving Licensing Authority.
Alcohol dependence
“A cluster of behavioural, cognitive & physiological
phenomena that develop after repeated alcohol use &
which include a strong desire to take alcohol, difficulties
in controlling its use, persistence in its use despite
harmful consequences, with evidence of increased
tolerance and sometimes a physical withdrawal state.”
Indicators may include a history of withdrawal symptoms,
of tolerance, of detoxification(s) and/or alcohol related
fits.
Reference to ICD10 F10.2 – F10.7. inclusive is relevant.
Alcohol dependence, confirmed by medical enquiry,
requires cessation from driving until a six month period
free from alcohol problems has been attained.
Abstinence will normally be required, with normalisation
of blood parameters, if relevant.
Driver must notify Driving Licensing Authority.
Return To Driving
Will require satisfactory medical assessment from own
doctor(s) and may require independent medical
examination and blood tests. Consultant
support/referral may be necessary. 
See also under “Alcohol Related Seizures”.
RSA COVERS_body text  19/12/2012  10:10  Page 48
Sláinte agus Tiomáint | Medical Fitness To Drive Guidelines |  (Group 1 Drivers) 49
Údarás Um Shábháilteacht Ar Bhóithre
Road Safety Authority
Alcohol Problems Group 1 — Car, M/Cycle
Alcohol related seizures
Seizures associated with alcohol are not considered
provoked for licensing purposes.
Alcohol related disorders
E.g. Hepatic cirrhosis with neuro-psychiatric impairment,
psychosis.
Following a solitary alcohol-related seizure, cessation
from driving for a minimum six month period from the
date of the event. Should however the seizure have
occurred on a background of alcohol the standards for
such conditions will need to be satisfied before a new
application can be considered. Where more than one
seizure has occurred, the Epilepsy Regulations will apply
(See Appendix to Neurological disorders chapter 2 for 
full details).Return to driving should only occur after an
appropriate period free from persistent alcohol misuse
and/or dependence. Independent medical assessment
with blood analysis and consultant reports will normally
be necessary.
Driving should cease until there is satisfactory recovery
and is able to satisfy all other relevant medical standards.
Driver must notify Driving Licensing Authority.
Drug Misues and Dependence
Reference to ICD10 F10.1-F10.7 inclusive is relevant
ODL — Car, M/Cycle
Cannabis
Amphetamines 
(Note: Metamphetamine Overleaf)
Ecstasy Ketamine & other psychoactive substances,
including LSD and Hallucinogens
Persistent use of or dependence on these substances,
confirmed by medical enquiry, requires cessation from
driving until a minimum six month period free of such
use has been attained. For Ketamine misuse or
dependence, 6 months off driving, drug-free, is required.
Independent medical assessment and urine screen
arranged may be required.
Driver must notify Driving Licensing Authority.
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Drug Misues and Dependence
Reference to ICD10 F10.1-F10.7 inclusive is relevant
ODL — Car, M/Cycle
Heroin
Methadone*
Cocaine
Metamphetamine 
Cannabis
Other illicit Substances
Persistent use of, or dependence on these substances,
confirmed by medical enquiry, requires cessation from
driving until a minimum 6 month period free of such use
has been attained. Independent medical assessment and
urine screen may be required. In addition favourable
Consultant or Specialist report maybe required on
reapplication.
* Applicants or drivers who are complying fully and are
stable on a supervised oral Methadone substitution
programme may continue to drive, subject to favourable
assessment and normally, annual medical review.
Applicants or drivers on an oral buprenorphine
programme may be considered applying the same
criteria. There should be no evidence of continuing use 
of illicit substances.
Driver must notify Driving Licensing Authority.
Benzodiazepines
The non-prescribed use of these drugs and/or the use 
of supra-therapeutic dosage, whether in a substance
withdrawal/maintenance programme or otherwise,
constitutes misuse/dependence for licensing purposes.
The prescribed use of these drugs at therapeutic doses
(MIMS/BNF), without evidence of impairment, does not
amount to misuse/dependence for licensing purposes
(although clinically dependence may exist).
Persistent misuse of, or dependence on these
substances, confirmed by medical enquiry, requires
driving cessation until a minimum 6 month period free 
of such use has been attained. Independent medical
assessment and urine screen may be required.
In addition favourable Consultant or Specialist report
may be required on reapplication.
Driver must notify Driving Licensing Authority.
Multiple substance misuse and/or dependence — including misuse with alcohol — is incompatible with
continued driving.
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Drug Misues and Dependence
Reference to ICD10 F10.1-F10.7 inclusive is relevant
Group 1 Entitlement 
ODL — Car, M/Cycle
Seizure(s) associated with drug misuse/dependence 
Seizures associated with drug misuse/dependence are
not considered provoked for licensing purposes.
Following a solitary seizure associated with drug misuse
or dependence, driving must cease for a minimum six
month period from the date of the event. Should
however, the seizure have occurred on a background of
substance misuse or dependence, the standards for such
conditions will also need to be satisfied before return to
driving. Where more than one seizure has occurred, the
Epilepsy Regulations will apply (See Appendix
Neurological disorders chapter 2 for full details). 
Medical enquiry will be required before driving to
confirm appropriate period free from persistent drug
misuse and/or dependence. Independent medical
assessment with urine analysis and consultant reports
will normally be necessary.
Driver must notify Driving Licensing Authority.
NB: A person who has resumed driving following persistent drug misuse or dependence must be 
advised as part of their after-care that if their condition recurs they should cease driving and notify their
Driving Licensing Authority.
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Chapter 7
Visual disorders
A licence holder or applicant must meet the standards for visual acuity and fields (assessed by confrontational visual
field test in the first instance) as outlined below, and if there is reason to doubt that these are adequate, the
applicant or licence holder should undergo a more detailed examination by a specialist (an ophthalmologist or
orthoptist other medical practitioner with a special interest in defects of eyesight or optometrist).
See Appendix to this chapter, Item A, Elements which should be assessed in more detailed assessment.
Registration as ‘blind’ with the National Council for the Blind in Ireland will normally be regarded as incompatible
with holding a driving licence and the driver must cease driving. However, attention will be given to the standards
indicated below in deciding on fitness to drive.
Visual Disorders Group 1 — Car, M/Cycle
Acuity Must have binocular visual acuity, with corrective lens 
as necessary, of at least 0.5 decimal (6/12 on a Snellen
chart). 
If the patient has an illness likely to cause progressive
loss of visual acuity the Driving Licensing Authority must
be notified and on the advice of a competent medical
authority, a 1, or 3 year licence may be appropriate.
Monocular vision
(Includes the use of one eye only for driving)
Complete loss of vision in one eye (ie. if there is any light
perception, driver is not considered monocular). Must
notify licensing authority but may drive when clinically
advised by a competent medical authority that driver has
adapted to the disability and the prescribed eyesight
standard in the remaining eye can be satisfied and
there is a normal monocular visual field in the remaining
eye, i.e. there is no area of defect which is caused by
pathology.
Driver must inform Driving Licensing Authority if 
medical advice is to cease driving for six months or
longer.
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Visual Disorders Group 1 — Car, M/Cycle
Visual field defects
Disorders such as severe bilateral glaucoma, severe
bilateral retinopathy, retinitis pigmentosa and other
disorders producing significant field defect including
partial or complete homonymous hemianopia/
quadrantanopia or complete bitemporal hemianopia.
Driving must cease unless confirmed that the horizontal
visual field is at least 120 degrees, the extension is at
least 50 degrees left and right and 20 degrees up and
down. No defects should be present within a radius of
the central 20 degrees.
If the patient has an illness likely to cause progressive
loss of visual field, Driving Licensing Authority must be
notified and on advice by a competent medical
authority, a 1 or 3 year licence may be appropriate. 
See item B of Appendix at end of this chapter for
guidance on more detailed assessment of visual fields
See Appendix C for consideration as an exceptional case
if not meeting these standards.
Diplopia Cease driving on detection. Resume driving on
confirmation to the licensing authority that the diplopia
is controlled by glasses (with or without a prism) or by a
patch which the licence holder undertakes to wear while
driving. (If patching, note requirements above for
monocularity). Exceptionally a stable uncorrected
diplopia of appropriate duration (for example, 6 months)
or more may be compatible with driving if there is
support from a competent medical authority indicating
satisfactory functional adaptation. 
For treated decompensated phoria, driving can resume
without informing Driving Licensing Authority.
Night blindness Acuity and field standards must be met. Cases should be
considered on an individual basis by an appropriately
qualified medical authority.
Colour blindness Need not notify licensing authority. Driving may
continue with no restriction on licence.
See Appendix at end of this chapter 
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Appendix 7
A. Elements which should be assessed in more detailed assessment
Visual acuity, field of vision, twilight vision, glare and contrast sensitivity, diplopia and other visual functions that
can compromise safe driving: adjudication determined by clinical judgement. 
B. Guidance on formal field of vision testing
The minimum field of vision for safe driving is defined as “A field of at least 120° on the horizontal measured using
a target equivalent to the white Goldmann III4e settings. In addition there should be no significant defect in the
binocular field which encroaches within 20° of fixation above or below the horizontal meridian”.
This means that homonymous or bitemporal defects, which come close to fixation, whether hemianopic or
quadrantanopic, are not normally accepted as safe for driving.
If a visual field assessment is necessary to determine fitness to drive, a number of tests are possible: in the UK and
Australia, for example, a binocular Esterman field is recommended. Monocular full field charts may also be requested
in specific conditions. Exceptionally, Goldmann perimetry, carried out to strict criteria, will be considered. For an
Esterman binocular chart to be considered reliable for licensing, the false positive score must be no more than 20%.
When assessing monocular charts and Goldmann perimetry, fixation accuracy will also be considered.
Defect affecting central area only
Pending the outcome of current research, the following are generally regarded as acceptable central loss as 
measured by the Esterman field method:
• Scattered single missed points
• A single cluster of up to 3 adjoining points
The following are generally regarded as unacceptable (i.e. ‘significant’) central loss as measured by the Esterman
field method:
• A cluster of 4 or more adjoining points that is either wholly or partly within the central 20 degree area.
• Loss consisting of both a single cluster of 3 adjoining missed points up to and including 20 degrees from fixation,
and any additional separate missed point(s) within the central 20 degree area
• Any central loss that is an extension of a hemianopia or quadrantanopia of size greater than 3 missed points.
Defect affecting the peripheral areas – width assessment
The following will be disregarded when assessing the width of field:
• A cluster of up to three adjoining missed points, unattached to any other area of defect, lying on or across the
horizontal meridian
• A vertical defect of only single point width but of any length, unattached to any other area of defect, which
touches or cuts through the horizontal meridian.
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C. Exceptional cases
Drivers who have previously held full driving entitlement, removed because of a field defect which does not satisfy
the standard, may be eligible to be considered as exceptional cases on an individual basis by a competent medical
authority, subject to strict criteria.
The defect must have been:
• Present for at least 12 months 
• Caused by an isolated event or a non-progressive condition and
• There must be no other condition or pathology present which is regarded as progressive and likely to be affecting
the visual fields.
In order to meet the requirements of European law, the Driving Licensing Authority will, in addition, require: 
• Clinical confirmation of full functional adaptation
• A satisfactory practical driving assessment, carried out by an appropriately qualified driving assessor, must
subsequently be completed.  
Note: An individual who is monocular cannot be considered under exceptional case criteria
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Renal Disorders Group 1 Entitlement 
ODL — Car, M/Cycle Group 1 — Car, M/Cycle
Chronic Renal Failure
CAPD (Continuous ambulatory peritoneal dialysis)
Haemodialysis
No restriction on holding a ten year licence, or if over 60
a licence that expires at age 70 unless subject to severe
electrolyte disturbance or significant symptoms, e.g.
sudden disabling attacks of dizziness or fainting or
impaired psychomotor or cognitive function when
driving should cease until the symptoms are controlled.
Hemodialysis patients should not travel distances more
than 1—2 days driving time from their home without
making arrangements for dialysis at another centre. 
They should not drive for at least 24 hours after missing
a dialysis treatment, and resume driving when dialysis
resumed and condition stabilized.
All other Renal Disorders Need not notify licensing authority unless associated
with a relevant disability.
Chapter 8
Renal disorders
Respiratory and Sleep Disorders Group 1 Entitlement 
ODL — Car, M/Cycle Group 1 — Car, M/Cycle
Sleep Disorder
Including Obstructive Sleep Apnoea Syndrome causing
excessive daytime/awake time sleepiness.
Helpful driver information can be found at www.rsa.ie
Driving must cease until satisfactory control of
symptoms has been attained.
Driver must notify Driving Licensing Authority.
Respiratory Disorders
Including asthma, COPD (Chronic Obstructive Pulmonary
Disease, Cough Sycope).
Driving Licensing Authority need not be notified unless
attacks are associated with disabling giddiness, fainting
or loss of consciousness.
Carcinoma of Lung Driving Licensing Authority need not be notified unless
cerebral secondaries are present.
(See Chapter 2 for Malignant Brain Tumour)
Chapter 9
Respiratory and Sleep Disorders
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Miscellaneous Conditions Group 1 Entitlement 
ODL — Car, M/Cycle Group 1 — Car, M/Cycle
Deafness (Profound) Need not notify Driving Licensing Authority. 
Brain Tumours Please refer to the appropriate section of Chapter 1.
Lung Cancer Please refer to the appropriate section of Chapter 7.
Other Cancers
For all tumours, fitness to drive depends upon:
The prospective risk of a seizure:
For Group 1 entitlement, Driving Licensing Authority does not need to be notified unless there are cerebral
metastases or significant complications of relevance (See subsequent bullet points for guidance).
AIDS Syndrome Driving may continue providing medical enquiries
confirm no relevant associated disability likely to affect
driving. 1 or 3 year licence with medical review
Driver must notify Driving Licensing Authority.
HIV Positive Need not notify Driving Licensing Authority. 
Age (Older Drivers) Age is no bar to the holding of a licence and physical
frailty is not per se a bar to the holding of a licence.
Please see the section 3.5 on multiple morbidity, and
relevant specific section for relevant diseases which are
more common later in life, such as stroke and dementia. 
Hypoglycaemia 
From any cause other than the treatment of Diabetes 
If suffering episodes of severe hypoglycaemia should
cease driving while liable to these episodes. Examples
would include after bariatric surgery or in association
with eating disorders.
Chapter 10
Miscellaneous conditions
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Impairment of cognitive function
E.g. Post Stroke, Post Head Injury, Early Dementia
There is no single or simple marker for assessment of impaired cognitive function, although the ability to manage day
to day living satisfactorily is a possible yardstick of cognitive competence. See Sections on dementia, maximising
treatment and in-car assessments, and on the road with a valid licence, are invaluable methods of ensuring that there
are no features present liable to cause the patient to be a source of danger, e.g. poor judgement, visual inattention,
easy distractibility, and difficulty performing multiple tasks. In addition, it is important that reaction time, memory,
concentration and confidence are adequate and do not show impairment likely to affect driving performance.    
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Patient Advisory Form 
Dear 
Following your assessment today, _____ /_____ /_____, I am advising you that you need to contact your Driving Licensing 
Authority to let them know that you have a condition _____________________ which may impact on your fitness to drive: 
I am also advising that: 
The philosophy of the NDLS is an enabling one, aiming to maximize mobility of drivers to the greatest extent possible. However, 
it is important to ensure that an appropriate balance is found between mobility and safety and the NDLS is likely to request you 
to provide a medical report clarifying your medical fitness to drive once you have notified them. The conditions that require 
reporting to your Driving Licensing Authority are outlined in the declaration made by you when you applied for, or renewed, 
your driving licence (see below) and also in the official RSA guidelines for medical fitness to drive, Sláinte agus Tiomáint. 
You should also clarify with your insurer as to whether or not this condition needs to be reported to them as well. A record of 
this notification will be held in your medical file here.
Yours sincerely
1. Diabetes treated by insulin and or sulphonylurea tablets (doctor to advise
whether patient is on these or not) no need to tell us if managed by other
tablets and or diet 
2. Epilepsy
3. Stroke or TIAs with any associated symptoms lasting longer than one month
4. Fits or blackouts
5. Any type of brain surgery, brain abscess or severe head injury involving 
in-patient treatment or brain tumour or spinal injury or spinal tumour
6. An implanted cardiac pacemaker
7. An implanted cardiac defibrillator (ICD)
8. Repeated attacks of sudden disabling dizziness 
9. Any other chronic neurological condition such as multiple sclerosis, 
motor neurone disease, Parkinson disease and Huntington’s disease 
10. A serious problem with memory or periods of confusion.
11. Persistent alcohol misuse or dependency
12. Persistent drug misuse or dependency
13.  Serious psychiatric illness or mental health problems
15.  Sleep Apnoea Syndrome
16.  Narcolepsy
17.  Any condition affecting the drivers peripheral vision 
18.  Total loss of sight in one eye
19.  Any condition affecting both eyes, or the remaining eye if driver only has one
eye (Not including colour blindness or short or long sight)    
20.  A serious hearing deficiency
21.  Any persisting problem with arm(s) or leg(s) which needs driving to be 
restricted to certain types of vehicle or those with adapted controls
22.  Is the driver’s vehicle adapted because of a physical disability to enable
you to drive 
23.  Severe learning disability
The above list is not exhaustive
Please note if you are the holder of an EU licence from a country other than Ireland, or hold a licence from a recognised country for licence exchange 
purposes, you should contact the licensing authority to arrange for a licence exchange and medical report.
Medical conditions requiring declaration at application for and renewal of driving licence
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FORM D501
Driving Licensing Medical Report Form
To drive you must meet certain medical fitness standards. For this purpose vehicles are classed as Group 1 and Group 2. 
If you are applying for a vehicle in both Groups (See Note 2 overleaf) please tick Group 1 and 2 on this form. Where an applicant
meets the medical criteria for Group 2 vehicles, they will automatically meet the medical criteria for Group 1 vehicles.
I, wish to undergo a medical examination on foot of my application for a learner permit/driving licence as required by the Road
Traffic Acts (See Note 1 Overleaf)
My application is for a driving licence/ learner permit as a driver of a: 
Group 1 or Group 2 vehicle. (See note 2 overleaf)
If you have in the past suffered or currently suffer from epilepsy, 
Please indicate the date of your last seizure.
Signature:
(To be signed in the presence of your Medical Practitioner)
THIS FORM MUST BE SUBMITTED TO A LICENSING AUTHORITY WITH AN APPLICATION FOR A DRIVING LICENCE/LEARNER PERMIT
WITHIN ONE MONTH OF ITS COMPLETION BY A MEDICAL PRACTITIONER.
Family Name/Surname
First Name(s)
Current Address
Date of Birth   D D M M Y Y Y Y
D D M M Y Y Y Y
D D M M Y Y Y Y
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To be completed by a Medical Practitioner whose name is on the General Register of Medical Practitioners in Ireland.
I, the undersigned registered medical practitioner report that:
•   The applicant has signed the declaration in my presence
•   I have examined the applicant by reference to the medical fitness standards required by the Road Traffic Acts and in my 
opinion, the applicant. (Please tick the appropriate box(es) below)
Meets the prescribed medical fitness standard set out for vehicles in Group 1              *Group 2
*(Place “X” in Group 2 box if NOT applicable)
Is fit to drive for a period of             1 year                     3 years                   5 years or 10 years (see note 3 overleaf)
The applicant has a physical disability which requires that adaptations be made to a vehicle to meet the
requirements of his/her disability.
The applicant has had a limb prosthesis/orthesis The applicant needs to wear corrective lenses while driving
Is medically unfit to drive
My opinion as to the applicant’s medical fitness is that the applicant is fit to drive vehicles of the Group indicated from any date
up to four calendar months from today’s date.
Signature:  
Date of Examination
FORM D501
Driving Licensing Medical Report Form
D D M M Y Y Y Y
Group 1 Vehicles and Licence Category Group 2 Vehicles and Licence Category
AM
C
A C1
A1 CE
A2 C1E
B D
BE D1
W DE
D1E
Medical Practitioner whose name is on the 
General Register of Medical Practitioners in Ireland
Medical Practitioner’s Telephone Number
Explanatory Notes
1. To complete your medical examination you must go to your
doctor, have your medical examination and sign this form in
the presence of the doctor. When the form is completed by
your doctor you must send it to a licensing authority with
your learner permit/driving licence application within one
month of the date of the medical examination.
2. For medical fitness standards vehicles are classed as being in
Group 1 or Group 2. The Table describes which vehicles are in
Group 1 and in Group 2. Further information on each licence
category can be found on the licence application form.  
A higher standard of medical fitness is required of those 
drivers who hold licences for Group 2 vehicles.
3. A person driving a Group 2 category vehicle must be certified
as medically fit every five years.
4. Applicants over 70 years of age can only be certified as being
fit to driver for either one or three years.
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FORM D502
Driving Licensing Eyesight Report Form
To drive you must meet certain medical fitness standards. For this purpose vehicles are classed as Group 1 and Group 2. If you are
applying for a vehicle in both Groups (See Note 2 overleaf) please tick Group 1 and 2 on this form. Where an applicant meets the
medical criteria for Group 2 vehicles, they will automatically meet the medical criteria for Group 1 vehicles.
I, wish to undergo an eyesight test on foot of my application for a learner permit/driving licence as required by the Road Traffic Acts. 
My application is for a driving licence/learner permit as a driver of a: 
Group 1 or Group 2 vehicle. (See note 1 overleaf)
Signature:
(To be signed in the presence of your Medical Practitioner)
This form must be submitted to a licensing authority with an application for a driving licence/learner permit within one month of
its completion by a medical practitioner or optometrist.
Family Name/Surname
First Name(s)
Current Address
Date of Birth   D D M M Y Y Y Y
D D M M Y Y Y Y
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To be completed by a medical doctor or optometrist whose name is in the General Register of Medical Practitioners or in the
Register of Optometrists in Ireland.
I, the undersigned registered medical practitioner/registered optometrist (delete as appropriate), report that:
•   The applicant has signed the declaration in my presence
•   I have examined the eyesight of the applicant by reference to the prescribed standard and in my opinion, the applicant 
(Please tick the appropriate box(es) below)
Meets the prescribed standard set out for vehicles in the Driver Fitness Medical Guidelines  Group 1             *Group 2
(See notes 3 and 4 overleaf) *(Place ‘X’ in Group 2 box if NOT applicable) 
Needs to wear corrective lenses to meet the standard set out below. 
Should be considered for limited duration of:
Group 1 Vehicles and Licence Category                1 year                     3 years                        10 years
Group 2 Vehicles and Licence Category                1 year                     3 years                        5 years 
(Maximum duration of a licence for group 2 driver)
Fails to meet the standard set out below  (Please see Notes 3 and 4 overleaf)
My opinion as to the applicant’s eyesight is that the applicant is fit to drive vehicles of the Group indicated from any date up to
four calendar months from todays date.
Signature:                                                                         
Date of Examination
FORM D502
Driving Licensing Eyesight Report Form
D D M M Y Y Y Y
Stamp of Medical Practitioner or Ophthalmic 
Optician whose name is on the register in Ireland
Medical Practitioner’s Telephone Number
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Explanatory Notes
1. For medical fitness standards vehicles are
classed as being in Group 1 or Group 2. The
Table below describes which vehicles are in
Group 1 and in Group 2. Further information
on each licence category can be found on the
licence application form.  
2. The following is general guidance 
for the medical or optical professional
carrying out the eyesight test. This advice 
will be superseded by guidance set out in the
Sláinte agus Tiomáint document which
represents the most up to date information
on medical fitness standards for drivers in
Ireland. All applicants for a driving licence 
shall undergo a visual acuity and
confrontational field test to ensure that they
have adequate eyesight for driving power-
driven vehicles. Where there is reason to
doubt that the applicant’s vision is adequate,
he/she shall be examined by a specialist (an
ophthalmologist or orthoptist other medical
practitioner with a special interest in defects
of eyesight or optometrist). At this
examination attention shall be paid, in
particular, to the following: visual acuity,
field of vision, twilight vision, glare and
contrast sensitivity, diplopia and other visual
functions that can compromise safe driving.
3. Group 1 Vehicles, Guidance for Medical
Professionals the following applies:
A. licensing may be considered in exceptional
cases where the visual field standard or visual
acuity standard cannot be met; in such cases
the driver should undergo examination 
by a competent medical authority to 
demonstrate that there is no other
impairment of visual function, including
glare, contrast sensitivity and twilight vision.
The applicant should also be subject to a
positive practical test.
B. The person shall have a binocular visual
acuity, with corrective lenses if necessary, of
at least 0,5 (6/12) when using both eyes
together. The horizontal visual field should be
at least 120 degrees, the extension should be
at least 50 degrees left and right and 20
degrees up and down. No defects should be
present within a radius of the central 20
degrees.
C. When a progressive eye disease is detected
or declared, driving licences may be issued or
renewed subject to the applicant undergoing
regular examination by a competent medical
authority.
D. A person who has total functional loss of
vision in one eye or who uses only one eye
must have a visual acuity of at least 0,5
(6/12), with corrective lenses if necessary.
The eyesight examining doctor or optometrist
must certify that this condition of monocular
vision has existed for a sufficiently long time
to allow adaptation and that the field of
vision in this eye meets the requirement laid
down in paragraph (B).
E. After any recently developed diplopia or
after the loss of vision in one eye, there
should be an appropriate adaptation period
(of at least six months), during which driving
is not allowed. After this period, driving is
only allowed following a favourable opinion
from the eyesight examining doctor or
optometrist.
4. Group 2 Vehicles, Guidance for Medical
Professional the following applies:
A. The person shall have a visual acuity, with
corrective lenses if necessary, of at least 0,8
(6/7.5)in the better eye and at least 0,1
(6/60) in the worse eye. If corrective lenses
are used to attain the values of 0,8 (6/7.5)
and 0,1 (6/60), the minimum acuity must be
achieved either by correction by means of
glasses with a power not exceeding plus eight
dioptres, or with the aid of contact lenses.
The correction must be well tolerated. The
horizontal visual field with both eyes should
be at least 160 degrees; the extension should
be at least 70 degrees left and right and 30
degrees up and down. No defects should be
present within a radius of the central 30 degrees.
B. A learner permit/driving licence should 
not be issued to a person who suffers from
impaired contrast sensitivity or from diplopia.
C. After a substantial loss of vision in 
one eye, there should be an appropriate
adaptation period (of at least six months)
during which the person is not permitted 
to drive. After this period, driving is only
permitted following a favourable opinion
from the eyesight examining doctor or
optometrist.
5. More information about medical fitness
standards is available on the www.rsa.ie
website under the driver licensing tab.
Group 1 Vehicles and Licence Category Group 2 Vehicles and Licence Category
AM
C
A C1
A1 CE
A2 C1E
B D
BE D1
W DE
D1E
FORM D502
Driving Licensing Eyesight Report Form
RSA COVERS_body text  19/12/2012  10:10  Page 64
W
orkin
g To Save Lives      
Údarás Um Shábháilteacht Ar Bhóithre
Road Safety Authority
Páirc Ghnó Ghleann na Muaidhe, Cnoc an tSabhaircín, Bóthar Bhaile Átha Cliath, Béal an Átha, Co. Mhaigh Eo.
Moy Valley Business Park, Primrose Hill, Dublin Road, Ballina, Co. Mayo.
locall: 1890 50 60 80   fax: (096) 25 252   email: info@rsa.ie   website: www.rsa.ie
Sláinte agus Tiomáint
Medical Fitness to Drive Guidelines
(Group 1 Drivers)
RSA COVERS_cover  19/12/2012  10:12  Page 1
